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Abstract 
 Errors in segregation of genetic materials are detrimental to all organisms. The 
budding yeast ensures accurate chromosome segregation by employing a system called 
the spindle checkpoint. The spindle checkpoint, which consists of proteins such as Mad1, 
Mad2, Mad3, Bub1, and Bub3, monitors the attachment of microtubules to the 
chromosomes and prevents cell cycle progression until all chromosomes are properly 
attached.  
 To understand how the spindle checkpoint arrests cells in response to attachment 
errors at the chromosomes, we recruited different checkpoint proteins to an ectopic site 
on the chromosome by taking advantage of the binding of the lactose repressor (LacI) to 
the lactose operator (LacO). We found that cells expressing Bub1-LacI arrest in 
metaphase. The phenotype is in fact caused by dimerization of Bub1 when it is fused to 
LacI rather than the recruitment of Bub1 to chromosome. The cell cycle arrest by the 
Bub1 dimer depends on the presence of other checkpoint proteins, suggesting that the 
dimerization of Bub1 represents an upstream event in the spindle checkpoint pathway.  
 The results with the Bub1 dimer inspired us to fuse checkpoint proteins to each 
other to mimic protein interactions that may contribute to checkpoint activation. We 
showed that fusing Mad2 and Mad3 arrests cells in mitosis and that this arrest is 
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independent of other checkpoint proteins. We believe that combining Mad2 and Mad3 
arrests cells because both proteins can bind weakly to Cdc20, the main target of the 
spindle checkpoint, and the sum of these two weak bindings creates a hybrid protein that 
binds tightly to Cdc20. We reasoned that if Mad3's role is to make Mad2 bind tightly, 
artificially tethering Mad2 directly to Cdc20 should also arrest cells and this arrest should 
not depend on any other checkpoint components. Our experiments confirmed these 
predictions, suggesting that Mad3 is required for the stable binding of Mad2 to Cdc20 in 
vivo, that this binding is sufficient to inhibit APC activity, and that this reaction is the 
most downstream event in spindle checkpoint activation.  The interactions among spindle 
checkpoint proteins thus play an important role in cell cycle arrest and must be carefully 
regulated. 
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Abstract 
 A cell has to undertake the complicated tasks of duplicating and segregating its 
genetic materials in order to proliferate. Eukaryotes have multiple systems to ensure the 
order and fidelity of these events. Chromosomes are separated during mitosis by 
microtubules, which attach to chromosomes by binding to a protein complex called the 
kinetochore. The spindle checkpoint ensures the accuracy of chromosome segregation by 
monitoring microtubule attachments at the kinetochores. When even a single kinetochore 
is not properly attached, the spindle checkpoint stops cell cycle progression and provides 
an opportunity for the cells to correct the attachment errors. The cell cycle arrest is 
achieved by inhibiting the E3 ubiquitin ligase named the anaphase-promoting complex 
(APC) and its co-activator Cdc20. How events at the kinetochore lead to inhibition of 
APCCdc20 by the spindle checkpoint components is still not clear. This chapter will 
summarize what the field currently knows about the spindle checkpoint by focusing on 
how checkpoint proteins interact with the kinetochore and how the checkpoint ultimately 
inhibits the activity of APCCdc20.     
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Introduction 
The cell cycle consists of a set of processes a cell has to execute in a controlled 
and timely manner to successfully form two viable and genetically identical cells (Figure 
1-1) (reviewed in [1]). One main event during the cell cycle is the duplication and 
segregation of genetic materials. In the budding yeast, Saccharomyces cerevisiae, the 16 
chromosomes replicate exactly once in synthesis (S) phase. The two identical copies of 
sister chromosomes are held together by the protein complex cohesin and are segregated 
from each other during mitosis, an elaborate process that consists of multiple steps. In 
metaphase, microtubules line up the duplicated chromosomes in the middle of the cells 
by attaching to the two sister kinetochores, specialized multi-protein structures that 
assemble on centromeric DNA and capture microtubules (reviewed in [2]). An E3 
ubiquitin ligase known as the anaphase-promoting complex (APC) and its co-activator 
Cdc20 then catalyze the ubiquitination and destruction of securin (Pds1 in budding 
yeast), which leads to the release of active separase (Esp1 in budding yeast) (Figure 1-
2A). Separase cleaves cohesin and destroys the linkage between sister chromosomes, 
ultimately triggering anaphase and chromosome segregation.  
Errors during the duplication and separation of chromosomes are usually 
detrimental to the cells. The accuracy of these events relies on the presence of multiple 
checkpoints, which generally work by preventing the cells from entering the next phase 
of the cell cycle unless the previous step is properly carried out. The spindle checkpoint, 
first identified in the budding yeast [3, 4], ensures correct chromosome segregation by 
monitoring the attachment and alignment of chromosomes on the mitotic spindle 
(reviewed in [5, 6]). When even a single chromosome is not properly attached, the  
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Figure 1-1. The budding yeast cell cycle. In G1 phase, budding yeast cells grow until they reach 
a size threshold. Cells then start budding and duplicating their chromosomes during the synthesis 
(S) phase. After that, cells enter mitosis, during which sister chromosomes move along 
microtubules to congress to the middle of the cell (metaphase) and are then segregated into the 
mother and daughter cell (anaphase). Cytokinesis and cell separation then occurs, and the two 
new cells can repeat the cell cycle to continue forming new progeny. 
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Figure 1-2. The control of metaphase-to-anaphase transition. (A) After DNA replication, the two 
sister chromosomes are held together by the protein complex cohesin. In metaphase, microtubules 
from opposite spindle poles attach to the duplicated chromosomes at the two sister kinetochores. 
After all the chromosomes are properly attached, an E3 ubiquitin ligase known as the anaphase-
promoting complex (APC) and its co-activator Cdc20 catalyze the ubiquitination and destruction 
of securin (Pds1 in budding yeast), thus releasing active separase (Esp1 in budding yeast). 
Separase cleaves cohesin and destroys the linkage between sister chromosomes, ultimately 
triggering anaphase and chromosome segregation. (B) When a single chromosome becomes 
unattached or when its two sister kinetochores are attached to microtubules from the same spindle 
pole, the spindle checkpoint is activated. The main goal of the checkpoint is to inhibit the activity 
of APCCdc20.  Inhibition of APCCdc20 stabilizes securin and keeps separase inactive. The spindle 
checkpoint hence arrests cells in metaphase until all chromosomes are properly attached.   
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spindle checkpoint will be activated. The main function of the spindle checkpoint is to 
inhibit the activity of APCCdc20, thus stabilizing securin and arresting cells before the 
metaphase-to-anaphase transition (Figure 1-2B).  The cell cycle arrest allows cells to 
achieve proper microtubule attachment at the kinetochores before progressing through the 
cell cycle, thus preventing chromosome missegregation.  
The components of the spindle checkpoint have been identified by several clever 
genetic screens which look for mutants that fail to respond to improper microtubule 
attachments. The spindle checkpoint components include the mitotic-arrest deficient 
(Mad) proteins Mad1, Mad2, and Mad3 [3], the budding uninhibited by benzimidazole 
(Bub) proteins Bub1 and Bub3 [4], Mps1 [7], Aurora B (Ipl1 in yeast) [8], and Sgo1 [9], 
all of which are highly conserved among eukaryotes. Despite knowing the identity of the 
main players, we still lack a detailed molecular description of how attachment errors at 
the kinetochore are converted into signals that inhibit APCCdc20.  
Below I will focus on two aspects of the spindle checkpoint that are crucial to our 
understanding of the system: (1) how the kinetochore interacts with components of the 
spindle checkpoint; and (2) how the spindle checkpoint proteins coordinate with each 
other to inhibit APC activity. I will summarize what we currently know about these areas 
as well as the unanswered questions that motivated my thesis work.   
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The Kinetochore: the Source of Spindle Checkpoint Signals 
 The spindle checkpoint is activated when chromosomes fail to attach to the 
mitotic spindle properly. Normal chromosome segregation depends on the two sister 
kinetochores attaching to microtubules from opposite spindle poles during mitosis (bi-
orientation). The pulling force from the microtubules is balanced by cohesion between 
the sister chromatids, generating tension across the kinetochores. Bi-orientation is the 
only attachment state that supports an even segregation of chromosomes during mitosis. 
The spindle checkpoint is activated by the absence of microtubule attachment [3, 4, 10] 
or the lack of tension at the kinetochore (because of sister chromosomes attaching to the 
same spindle pole) [11-13] and leads to cell cycle arrest (Figure 1-2B), thus ensuring that 
all chromosomes are bi-oriented before the cell enters anaphase.  
The kinetochore, with its role in binding microtubules, is thought to be the major 
site for generating spindle checkpoint signals. Supporting this, budding yeast mutants 
with compromised kinetochore structures fail to activate the checkpoint even in the 
presence of microtubule poisons [14, 15], showing that kinetochore components are 
normally required to initiate the checkpoint pathway. It is important for cells to only 
arrest when the chromosomes are not properly attached. The kinetochore should therefore 
be able to accurately sense the status of microtubule attachment and interact with the 
spindle checkpoint components accordingly. How this is achieved is still poorly 
understood. 
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Spindle Checkpoint Proteins at the Kinetochore 
While a unifying description of how the kinetochore talks to the checkpoint 
proteins is still lacking, studies by many different labs lead to several working models on 
how the checkpoint components interact with the kinetochore and each other to generate 
inhibitory signals. Currently the most widely accepted model is the conformational 
change (Mad2-template) model [5], which is based on the structures of different 
conformations of Mad2 [16-19], structural analysis of the Mad1-Mad2 complex [18], and 
imaging the dynamics of checkpoint proteins at the kinetochore [20-24]. In this model, 
free Mad2 exists in an open conformation (O-Mad2) that is unable to interact with Mad1 
and Cdc20. In the absence of microtubule attachment, the kinetochore recruits Mad1 
dimers, which in turn bind Mad2 (Figure 1-3). This leads to the formation of a Mad1-
Mad2 complex with Mad2 in the closed conformation (C-Mad2), which wraps around 
Mad1. The complex recruits free open Mad2 and facilitates its conversion into closed 
Mad2 and association with Cdc20. The conformational change is important since the 
closed conformation of Mad2 is required for the binding and inhibition of Cdc20 [23, 25]. 
The Mad1-Mad2 complex is thought to be essential for “priming” the conversion of 
Mad2 from open to closed form and thus allows the production of a closed Mad2-Cdc20 
complex [26]. The Mad2-Cdc20 complex acts as a diffusible signal and ultimately leads 
to inhibition of APC activity (discussed below).  
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Figure 1-3. The Mad2-template model. Mad1 dimers associate with unattached kinetochores and 
bind Mad2, converting them from “open” (O-Mad2) to “closed” (C-Mad2) conformation. The 
Mad1-Mad2 complexes at the kinetochores (the “templates”) then recruit free open Mad2, 
facilitating the formation of closed Mad2-Cdc20 complexes. The Mad2-Cdc20 complex acts as a 
diffusible checkpoint signal from the kinetochore and leads to the inhibition of APC.  
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One important extension from the Mad2-template model is that the closed Mad2-
Cdc20 complex can recruit open Mad2 and trigger the production of additional closed  
Mad2-Cdc20, thereby amplifying the checkpoint signal [5]. This can potentially explain 
how a single improperly attached kinetochore can generate a strong enough signal to 
completely inhibit APCCdc20 activity. But our work using a system that allows Mad2 to 
associate constitutively with Cdc20 suggests that a Mad2-Cdc20 complex is unable to 
further inhibit free Cdc20 (discussed in Chapter 4). An alternative mechanism is hence 
required to ensure complete inhibition of APCCdc20 during normal checkpoint activation, 
and identification of such mechanism will help us understand how even a single 
kinetochore can lead to cell cycle arrest.  
 Relatively little is known about how the Mad1-Mad2 complex interacts with the 
unattached kinetochore. Depletion of subunits of the kinetochore Ndc80 complex by 
RNAi affects the kinetochore association of Mad1, Mad2, and Mps1 [27, 28], indicating 
that the Ndc80 complex may be the kinetochore “receptor” that binds the Mad1-Mad2 
complex. Forcing the localization of Mad1 to the kinetochore in human tissue culture 
cells lead to recruitment of Mad2 and metaphase arrest [29], supporting the idea that 
association between Mad1 and the kinetochore is an integral part of the checkpoint 
pathway.  
Besides Mad1 and Mad2, other checkpoint proteins also have extensive 
interactions among each other and with the kinetochore. Bub1 has a relatively stable 
association with the kinetochore [22]. Localizing the checkpoint kinase Mps1 (Mph1 in 
fission yeast) to the kinetochore is sufficient to recruit Bub1 and activate the spindle 
checkpoint in fission yeast [30], showing that Mps1 may play a role in Bub1 recruitment 
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by phosphorylating certain kinetochore components. One possible Mps1 target is the 
kinetochore protein Blinkin (Spc105 in budding yeast), which is important for the 
kinetochore recruitment of Bub1 and BubR1 (the mammalian equivalent of Mad3) and 
checkpoint activation [31]. Localizing Bub1 to an ectopic site on the chromosome in 
fission yeast leads to recruitment of both Bub3 and Mad3, but fails to arrest the cell cycle 
[32]. Bub1 may therefore support the formation of a Bub1-Bub3-Mad3 complex at the 
kinetochore that is important but not sufficient for downstream checkpoint signaling.  
Based on the above findings, we favor a “kinetochore scaffold” model to explain 
how kinetochore leads to spindle checkpoint activations [33]. Both Mad1 and Bub1 
associate with unattached kinetochores and act as the main scaffolds. They recruit Mad2, 
Mad3, and Bub3 to the kinetochore, forming a Mad1-Mad2 and a Bub1-Bub3-Mad3 
complex (Figure 1-4). Bub1 associates with Mad1 in budding yeast [34], suggesting that 
the two complexes can potentially interact. Concentrating different checkpoint proteins 
together at the kinetochore may lead to formation of additional inhibitory complexes. 
One example is the mitotic checkpoint complex (MCC), which is proposed to consist of 
Mad2, Mad3, Bub3 and Cdc20 and has been shown to be a potent inhibitor of APCCdc20 
[35, 36] (Figure 1-4). The kinetochore thus acts as a hub for the recruitment of different 
checkpoint proteins to allow the production of inhibitory complexes. Certain components 
at the kinetochore may also modify the bound checkpoint proteins to further stimulate the 
inhibitory signals. In vitro experiments showed that purified kinetochores on 
chromosomes can stimulate MCC production [37], supporting the idea that the 
kinetochore is important for the efficient formation of downstream checkpoint effectors.  
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Figure 1-4. The kinetochore scaffold model. Mad1 and Bub1 associate with unattached 
kinetochores and act as the scaffolds. They recruit Mad2, Mad3, and Bub3 to the kinetochore, 
leading to the formation of a Mad1-Mad2 and a Bub1-Bub3-Mad3 complex. The two complexes 
may interact through the association between Mad1 and Bub1. Recruiting different checkpoint 
proteins to the kinetochore allows the formation of downstream inhibitory complexes, such as the 
mitotic checkpoint complex (MCC). The MCC consists of Mad2, Mad3, Bub3 and Cdc20 and is 
a potent inhibitor of APCCdc20. Inhibition of APCCdc20 stabilizes securin and arrests cells in 
metaphase in the presence of improperly attached kinetochores.  
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For proper checkpoint response, the formation of inhibitory complexes must be 
carefully regulated and should only happen in the absence of proper microtubule 
attachment. One way to achieve this regulation is to control the interaction between the 
Mad1 and Bub1 scaffolds, which is important for the downstream events in the spindle 
checkpoint pathway. Bub1 associates with the kinetochore stably [22], and Mad1 may 
only be able to bind Bub1 when microtubules are not properly attached to the 
kinetochore. The presence of microtubule at the kinetochore may physically block the 
interaction between Mad1 and Bub1. Microtubule binding may also lead to post-
translational modifications or structural changes to Bub1 and affect its binding to Mad1. 
In addition, microtubule attachment can change the overall structure of the kinetochore 
[38], which may further prevent Bub1 from associating with Mad1. Understanding the 
exact events at the kinetochore induced by microtubule attachment and their effects on 
checkpoint proteins recruitment and interaction will be an important area of future 
research.  
Another important aspect of the spindle checkpoint is that cells must be able to 
quickly recover from the checkpoint-induced arrest when all chromosomes are properly 
attached. Most studies have focused on how the cells get rid of the inhibitory checkpoint 
complexes, such as closed Mad2-Cdc20, once all the chromosomes are properly aligned. 
One possibility is that closed Mad2-Cdc20 complexes rapidly disassemble in the absence 
of Mad1-Mad2 complexes at the kinetochores, and an intrinsically fast off rate of closed 
Mad2 from Cdc20 is sufficient to allow cells to rapidly progress through the cell cycle 
once all kinetochores are attached. Cells may also have other mechanisms to actively 
silence the checkpoint. In animal cells, p31-comet is implicated for inactivating the 
! 14 
checkpoint by binding to closed Mad2, which may prevent further production of closed 
Mad2-Cdc20 complex or compete with Mad3 for binding to Mad2 and thus inhibiting 
assembly of the MCC [39-41]. Since p31-comet is not found in budding yeast, additional 
experiments are clearly needed before we can have a clear picture of how cells recover 
from the spindle checkpoint.  
 
Inhibition of APC Activity  
The ultimate goal of the spindle checkpoint is to inhibit the activity of APCCdc20. 
APC is a large multi-subunit E3 ubiquitin ligase that is essential for cell cycle progression 
by mediating ubiquitin-dependent degradation of different substrates (reviewed in [42]). 
The substrates of APC usually contain two destruction motifs; the D box (RxxLxxI/VxN) 
and the KEN motif (KENxxxN/D) [43-45]. The activity and substrate specificity of APC 
depends on its interactions with the co-activators Cdc20 and Cdh1 [46-49]. APCCdc20  is 
the main driving force for metaphase-to-anaphase transition by marking securin for 
destruction [50], thus breaking the connection between sister chromatids and allowing 
separation of the chromosomes. Inhibition of APC activity by the spindle checkpoint 
stabilizes securin, arrests cells in metaphase, and therefore prevents premature 
chromosome segregation.  
The mitotic checkpoint complex (MCC), made up of Mad2, Mad3, Bub3, and 
Cdc20, is considered to be the major inhibitor of APC activity. Several mechanisms have 
been proposed to explain the action of MCC. Mad2 and Mad3 promote Cdc20 
degradation during checkpoint activation [51, 52], which can interfere with APC activity. 
In addition, MCC can act as a pseudosubstrate of APC through the N-terminal KEN box 
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motif in Mad3 [53-55] and prevents proper binding of substrates. A recent crystal 
structure of the MCC from fission yeast shows that the KEN box-binding site of Cdc20 is 
occupied by Mad3, while the D box-binding site is oriented in a way that will also affect 
substrate binding [41]. The binding of Mad2 to Cdc20 can also potentially affect the 
interactions between Cdc20 and APC that are necessary for stimulating the catalytic 
activity of APC [41, 56]. Moreover, a model of MCC bound to APC derived from 
electron microscopy reveals that APC adopts a more closed rigid conformation when 
bound by MCC [57], which may further results in lower APC activity. It remains to be 
determined how the different mechanisms coordinate with each other to completely 
inhibit the activity of APCCdc20. 
 
Closing Remarks 
The spindle checkpoint is important for accurate chromosome segregation, a 
process that has to be tightly regulated to prevent disastrous results to the cells. 
Experiments employing many different techniques such as fluorescent microscopy and in 
vitro biochemical reconstitution have significantly advanced our understanding of the 
system. A complete picture of how the spindle checkpoint work will require additional 
studies to address questions such as the exact molecular events that allow the kinetochore 
to generate signals to inhibit cell cycle progression, which hopefully will be an 
achievable goal in the near future.  
 In Chapter Two of this thesis, I will summarize my attempt to test the 
“kinetochore scaffold” model by recruiting checkpoint proteins to the chromosome. The 
results from these experiments were confusing and often hard to interpret. Follow-up 
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experiments revealed that dimerizing the checkpoint protein Bub1 leads to spindle 
checkpoint activation, which I will discuss in Chapter Three. This work in turn promoted 
me to try fusing different checkpoint proteins together, and in Chapter Four I will 
describe how I concluded from these experiments that Mad2 and Mad3 act as one of the 
most downstream components in the checkpoint pathway by binding to Cdc20.  
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Abstract 
Correct chromosome segregation during mitosis depends on the spindle 
checkpoint, which monitors microtubule attachments at the kinetochore and arrests cells 
before the metaphase-to-anaphase transition until all chromosomes are properly attached. 
It is not clear how events at the kinetochore activate the spindle checkpoint and induce 
cell cycle arrest. To test the idea that the kinetochore leads to checkpoint activation by 
acting as a scaffold to localize checkpoint proteins, we artificially recruited different 
checkpoint components to the chromosome using binding of the lactose repressor (LacI) 
to the lactose operator (LacO). Cells carrying LacO repeats arrested in metaphase when 
they also expressed protein fusions of LacI fused to Bub1 and a mutant version of Bub3 
(BUB3-A117T). The results suggest that localizing Bub1 and BUB3-A117T to the 
chromosome is sufficient to activate the checkpoint, potentially by further recruiting 
other checkpoint components. Additional experiments showed that a small fraction of 
cells that did not have any LacO DNA activated the spindle checkpoint when they only 
expressed Bub1-LacI, which argues that Bub1-LacI can induce metaphase arrest even 
when it is not recruited to the chromosome.  
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Introduction 
Segregation of genetic materials is an integral part of the cell division cycle. In 
eukaryotes, DNA replication produces two identical copies of chromosomes, which are 
separated from each other in mitosis. Chromosome segregation relies on the pulling force 
of microtubules, which attach to the chromosome by binding to a protein complex called 
the kinetochore. When all chromosomes are attached by microtubules, the anaphase-
promoting complex (APC) and its co-activator Cdc20 catalyze the ubiquitination and 
destruction of securin, triggering anaphase and chromosome segregation. Any mistakes 
during these processes are likely detrimental. Cells are thus equipped with different 
mechanisms to ensure that all the steps are carried out properly and in the correct order.  
The spindle checkpoint is essential for accurate chromosome segregation by 
making sure that all chromosomes are lined up on the mitotic spindle before the cells 
enter anaphase. The spindle checkpoint consists of proteins including Mad1, Mad2, Mad3 
[1], Bub1, Bub3 [2], Mps1 [3], Ipl1 [4], and Sgo1 [5], which were first identified by 
screening for budding yeast mutants that fail to respond to microtubule attachment errors. 
When even a single kinetochore is not properly attached, the spindle checkpoint is 
activated and stops cell cycle progression by inhibiting the activity of APCCdc20. We still 
do not understand how events at the kinetochore signal to the spindle checkpoint and 
subsequently inhibit APC activity. One model is that in the absence of microtubule 
attachment, the kinetochore acts as a hub and recruits different spindle checkpoint 
proteins, ultimately facilitates the formation of inhibitory checkpoint complexes and 
leads to cell cycle arrest (the “kinetochore scaffold” model, discussed in Chapter One).  
 ! 25 
A prediction from the kinetochore scaffold model is that artificially forcing the 
localization of checkpoint proteins to the chromosome should mimic events at the 
unattached kinetochore, thus resulting in the formation of inhibitory complexes and 
checkpoint activation. Previous studies have looked at the effect of recruiting checkpoint 
proteins to different locations in the cells. Localizing Bub1 to the telomeres in fission 
yeast is sufficient to recruit Bub3 and Mad3, showing that Bub1 acts as a scaffold protein 
[6]. The recruitment of these checkpoint proteins to the telomeres has no effect on cell 
cycle progression, suggesting that additional components such as Mad1 and Mad2 are 
required to generate a checkpoint signal [6]. Recruiting the checkpoint kinase Mps1 
(Mph1 in fission yeast) to the kinetochore by fusing it to a core kinetochore protein 
induces the localization of Bub1 and cell cycle arrest in fission yeast cells [7]. Similarly, 
localizing Mad1 to the kinetochore in human tissue culture cells leads to recruitment of 
Mad2 and metaphase arrest [8], indicating that targeting Mad1 to the kinetochore is 
sufficient to activate the spindle checkpoint. These studies support the idea that 
localization of checkpoint proteins plays a crucial role in initiating the events in the 
spindle checkpoint pathway.  
 To look at the effect of localizing checkpoint proteins to an ectopic site in 
budding yeast, we developed a system that allows us to recruit different checkpoint 
components to the chromosome by using the binding of the lactose repressor (LacI) to the 
lactose operator (LacO). We showed that cells carrying LacO repeats arrested in 
metaphase when they also expressed LacI fused to Bub1 and a mutant version of Bub3 
(BUB3-A117T). The recruitment of Bub1 and BUB3-A117T to the chromosome may thus 
recruit other checkpoint components and activate the spindle checkpoint. Interestingly, 
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cells expressing Bub1-LacI alone (without LacO or BUB3-A117T-LacI) still showed 
metaphase arrest, which suggests that Bub1-LacI is able to induce checkpoint activation 
without being localized to the chromosome.  
 
Results  
A System for Recruiting Checkpoint Proteins to the Chromosome 
Recruitment of checkpoint proteins to an unattached kinetochore may represent an 
important step in checkpoint activation. To test this idea, we developed a system to 
determine the effect of artificially localizing checkpoint proteins to the budding yeast 
chromosome by exploiting the specific binding of the lactose repressor (LacI) to the 
lactose operator (LacO). We generated protein fusions of different checkpoint proteins 
(Mad1, Mad2, Mad3, Bub1 and Bub3) fused to the N terminus of LacI. We placed the 
constructs under the HIS3 promoter, which is expressed constitutively at a low level but 
can be further induced by growing cells in medium that lacks histidine and contains the 
compound 3-aminotriazole [9]. We also integrated a DNA array of 256 LacO repeats into 
the budding yeast chromosome III. When a LacI protein fusion is expressed in cells 
carrying the LacO repeats, the protein can be recruited to the chromosome through the 
binding of LacI to LacO.  
Since the LacI protein fusions are constitutively expressed, cells will fail to 
proliferate if recruiting the LacI fusions to the chromosome is able to induce metaphase 
arrest. To circumvent this problem, we introduced a dominant allele of Cdc20 (CDC20-
127) that the spindle checkpoint cannot inhibit [10]. The allele is expressed from a 
tetracycline-regulated promoter (Ptet). In the absence of the drug doxycycline, CDC20-
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127 is expressed, which overrides the checkpoint and allows cells to proliferate even 
when the checkpoint is activated (Figure 2-1A). Expression of the allele can be repressed 
by adding doxycycline, and we can then determine whether recruitment of certain 
checkpoint proteins will activate the spindle checkpoint (Figure 2-1B).   
 
Recruiting Bub1 and BUB3-A117T to the Chromosome Arrests Cells in Metaphase 
 To systematically test the effect of recruiting checkpoint components to the 
chromosome, we introduced either one or two different LacI protein fusions into strains 
with 256 LacO repeats and Ptet-CDC20-127. We then asked what will happen to yeast 
cells going through a synchronous cell cycle when the expression of the checkpoint-
resistant CDC20-127 is repressed. We arrested the cells in G1 with !-factor, then released 
them into rich media with or without doxycycline, and looked at them four hours later. 
We used the morphology of the cell as an indicator of cell cycle position. If cells activate 
the checkpoint and arrest in metaphase, they will be enlarged and have large buds similar 
to the size of the mother cells. On the other hand, cells that are cycling normally have no 
bud or buds that are smaller than the mother cell.   
Most strains that we tested had no obvious phenotype. Almost all the cells had no 
or small buds when CDC20-127 was repressed (data not shown). On the other hand, cells 
with 256 LacO repeats and which expressed a Bub1-LacI protein fusion showed a mild 
metaphase arrest. When doxycycline was added to the media (to inhibit CDC20-127 
expression), around 20% of the cells were large budded, an indicator of metaphase arrest 
(Figure 2-2). Growing cells in synthetic medium that does not contain histidine and with 
3-aminotriazole added (to increase expression of Bub1-LacI) led to a slightly stronger  
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Figure 2-1. Experimental set up to test the effect of recruiting checkpoint proteins to the 
chromosome. (A) Protein fusions of different checkpoint proteins fused to the N terminus of LacI 
were introduced into yeast cells carrying a DNA array of 256 LacO repeats on chromosome III. 
The expressed protein fusions are recruited to the chromosome through the specific binding of 
LacI to LacO. The cells also carry a dominant allele of Cdc20 (CDC20-127) that the spindle 
checkpoint cannot inhibit under a tetracycline-regulated promoter (Ptet). In the absence of the 
drug doxycycline, CDC20-127 is expressed, which allows cells to progress through anaphase 
even when the spindle checkpoint is activated. (B) When doxycycline is added to the media, the 
expression of CDC20-127 is inhibited. Cells will arrest in metaphase if the recruitment of 
checkpoint proteins activates the spindle checkpoint and inhibits Cdc20.   
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Figure 2-2. Recruiting Bub1 and BUB3-A117T to the chromosome induces metaphase arrest in 
cells. Cells with 256 LacO repeats on chromosome III, Ptet-CDC20-127, and the indicated PHIS3-
driven genes were released from G1 arrest into rich media without (-Dox) or with (+Dox) the drug 
doxycycline (to turn off expression of the checkpoint resistant CDC20-127). The percentage of 
large budded cells was determined by light microscopy after 4 hours of growth. Error bars 
represent the standard deviation of three independent trials. Two hundred cells were counted for 
each trial.   
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phenotype (data not shown), showing that the metaphase arrest depends on the 
concentration of Bub1-LacI. We noticed that the cells grew much slower and sometimes 
had strange morphologies in this case, therefore we decided to use rich media for all the 
subsequent experiments.   
The metaphase arrest induced by Bub1-LacI in cells carrying 256 LacO repeats 
was much stronger when BUB3-A117T-LacI, a mutant version of Bub3-LacI generated 
by lucky PCR mutation in the cloning process, was also expressed (Figure 2-2). In this 
case more than 40% of the cells were large budded in the presence of doxycycline. 
Expressing BUB3-A117T-LacI alone in cells with LacO repeats had no obvious 
phenotype (data not shown), suggesting that the stronger arrest is due to the mutant Bub3 
potentiating the checkpoint activation by Bub1-LacI. The effect was not observed when 
wild type Bub3-LacI was expressed instead (Figure 2-2), showing that A117T may be a 
gain-of-function mutation that enables Bub3 to strengthen the metaphase arrest. The 
crystal structure of the budding yeast Bub3 shows that it is a seven-bladed !-propeller 
and interacts with Bub1 and Mad3 through its top surface [11, 12]. The A117T mutation 
is located on one of the ! sheets and should not significantly affect the overall structure 
of Bub3 or its interaction with Bub1 and Mad3. Alternatively, the mutation from alanine 
to threonine may create a site for phosphorylation. Expressing BUB3-A117S-LacI, which 
should mimic phosphorylation of Bub3 at position 117, had little effect on the level of 
checkpoint activation in cells with Bub1-LacI and LacO repeats. It is therefore unlikely 
that the A117T mutation alters Bub3 function by allowing it to be phosphorylated. 
Additional experiments will be required to determine what effect the mutation may have 
on Bub3 function.  
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LacO Repeats Strengthen Checkpoint Activation by Bub1-LacI but are not 
Essential for the Arrest 
A model to explain the results so far is that when Bub1 is localized to the 
chromosome through the binding of LacI to LacO, it is able to act as a scaffold and 
recruits other checkpoint proteins such as Bub3 and Mad3 to the site. This is sufficient to 
activate the spindle checkpoint in a fraction of the cells. The metaphase arrest becomes 
much more pronounced in the presence of BUB3-A117T, which through some as yet 
unknown mechanisms is able to strengthen checkpoint activation. Our data therefore 
supports the idea that localizing checkpoint proteins represent an important step in the 
spindle checkpoint pathway. 
If the metaphase arrest we observed is due to localizing Bub1 to DNA, it should 
depend on the presence of LacO repeats on the chromosome. Even without LacO DNA, 
around 5% of cells expressing only Bub1-LacI arrested in metaphase (Figure 2-3). The 
result indicates that Bub1-LacI can activate the checkpoint even when it is not recruited 
to the chromosome, likely through a mechanism that does not require its ability to bind 
LacO. The phenotype is slightly stronger when BUB3-A117T-LacI or untagged BUB3-
A117T was also expressed (Figure 2-3), showing that the expression of BUB3-A117T 
alone, independent of its localization, can strengthen the metaphase arrest induced by 
Bub1-LacI.  
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Figure 2-3. The presence of LacO repeats strengthens the metaphase arrest induced by Bub1-
LacI by is not absolutely required. Cells with Ptet-CDC20-127, the indicated PHIS3-driven genes, 
and with (+LacO) or without (-LacO) 256 LacO repeats were released from G1 arrest into rich 
media without (-Dox) or with (+Dox) the drug doxycycline (to turn off expression of the 
checkpoint resistant CDC20-127). The percentage of large budded cells was determined by light 
microscopy after 4 hours of growth. Error bars represent the standard deviation of three 
independent trials. Two hundred cells were counted for each trial.   
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Conclusions and Discussion 
 We developed a system for recruiting checkpoint proteins to the chromosome by 
taking advantage of the specific binding of LacI to LacO. Our initial results suggested 
that recruiting Bub1 and BUB3-A117T to the budding yeast chromosome is sufficient to 
activate the spindle checkpoint. We still observed metaphase arrest in a small portion of 
cells when only Bub1-LacI was expressed, indicating that the checkpoint activation is 
caused by the fusion of Bub1 to LacI and does not completely depend on the recruitment 
of Bub1 to DNA.  
Expressing BUB3-A117T-LacI, but not wild type Bub3-LacI, led to a stronger 
metaphase arrest in cells expressing Bub1-LacI with or without LacO. The mutant Bub3 
therefore somehow potentiates the checkpoint activation by Bub1-LacI. This increase in 
cells arrested in metaphase was observed when untagged BUB3-A117T was expressed, 
showing that the mutant can exert its effect even when it is not fused to LacI. One 
interesting question is whether BUB3-A117T can also strengthen spindle checkpoint 
activation in response to other perturbations such as microtubule poisons. Replacing 
endogenous Bub3 with BUB3-A117T in wild type yeast cells did not have an obvious 
effect on the ability of the spindle checkpoint to arrest cells in the presence microtubule 
depolymerizing drugs (data not shown). It is possible that the mutant can potentiate 
checkpoint activation but our assay is not sensitive enough to detect the effect. Another 
important issue is how the mutation affects the function of Bub3. The mutation may 
affect the structure of Bub3 or alter its interactions with other checkpoint components. 
Experiments such as coimmunoprecipitation to look at how the mutant Bub3 interacts 
with other checkpoint proteins will be an interesting future direction.  
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We conclude from our results that Bub1-LacI is able to activate the spindle 
checkpoint through mechanisms that are induced by fusing Bub1 to LacI but independent 
of the ability of the protein fusion to bind LacO. Free Bub1-LacI is sufficient to arrest 
cells in metaphase, albeit weakly, presumably by interacting with other components of 
the spindle checkpoint and subsequently leads to checkpoint activation. We speculate that 
the more pronounced arrest in LacO repeat array-containing cells is due to the ability of 
the LacO repeats to increase the local concentration of Bub1-LacI by localizing the 
protein fusion to the chromosome, thus causing a stronger metaphase arrest. Overall our 
experiments revealed an unexpected effect of fusing Bub1 to LacI, which will be 
explained in Chapter Three, but did not conclusively address whether recruiting 
checkpoint proteins to an ectopic region can affect cell cycle progression. Alternative 
way of localizing checkpoint proteins, such as tethering them directly to kinetochore 
components, may potentially answer this question.  
  
 ! 35 
Materials and Methods  
Yeast strains and Methods 
 All strains are derivatives of W303 (ade2-1  his3-11,15  leu2-3,112  trp1-1  ura3-
1  can1-100), and are listed in Table 2-1. Strains were constructed using standard genetic 
techniques. All media were prepared using established recipes [13], and contain 2% 
wt/vol of glucose as the carbon source.  
 
Cell Cycle Analysis by Light Microscopy (Ptet-CDC20-127 strains) 
 To look at the effect of recruiting different checkpoint constructs to the 
chromosome on cell cycle progression, cells were first grown to mid-log phase (107 
cells/ml) in YEP with 2% glucose (wt/vol) (YPD). Cells were then arrested in G1 by 
adding 10µg/ml !-factor (Bio-Synthesis, Lewisville, TX) and incubated for 2 hours at 
30oC. Cells were washed four times to remove !-factor and resuspended in YPD with or 
without 10µg/ml doxycycline (Sigma-Aldrich, St. Louis, MO) to inhibit expression of 
CDC20-127. After growing for 4 hours at 30oC, the cultures were briefly sonicated to 
separate cells that fail to dissociate completely after division and the percentage of large-
budded cells in each sample was determined by light microscopy.  
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Table 2-1. Strains used in this Chapter.  
Strain Name Genotype 
DLY457 MATa  Ptet-CDC20-127@TRP1  PHIS3-BUB1-LacI@URA3 
DLY465 MATa  Ptet-CDC20-127@TRP1  LacO256@LEU2  PHIS3-BUB1-LacI@URA3 
DLY472 MATa  Ptet-CDC20-127@TRP1  LacO256@LEU2  PHIS3-BUB1-LacI@URA3  PHIS3-
BUB3-LacI@ADE2 
DLY481 MATa  Ptet-CDC20-127@TRP1  LacO256@LEU2  PHIS3-BUB1-LacI@URA3  PHIS3-
BUB3-A117T-LacI@ADE2 
DLY482 MATa  Ptet-CDC20-127@TRP1  PHIS3-BUB1-LacI@URA3  PHIS3- BUB3-A117T-
LacI@ADE2 
DLY518 MATa  Ptet-CDC20-127@TRP1  LacO256@LEU2  PHIS3-BUB1-LacI@URA3  PHIS3- 
BUB3-A117S-LacI@HIS3 
DLY552 MATa  Ptet-CDC20-127@TRP1  PHIS3-BUB1-LacI@URA3  PHIS3- BUB3-A117T 
@HIS3 
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Abstract 
 We developed a system for recruiting checkpoint proteins to the chromosome to test the 
model that the kinetochore activates the spindle checkpoint by acting as a hub for binding 
different checkpoint proteins. We found that cells expressing Bub1-LacI in the presence of LacO 
repeats arrest in metaphase, which suggests than the localization of Bub1 to the chromosome can 
activate the spindle checkpoint. Here we show that expression of Bub1-LacI can arrest cells even 
in the absence of LacO repeats. The phenotype is caused by dimerization of Bub1 when it is 
fused to LacI. The cell cycle arrest by the Bub1 dimer requires the presence of most checkpoint 
proteins, suggesting that it is acting upstream in the spindle checkpoint pathway. Expressing the 
Bub1 dimer affects chromosome bi-orientation, but the metaphase arrest doesn’t depend on the 
presence of functional kinetochores, showing that the Bub1 dimer may activate the checkpoint 
through multiple mechanisms. We found that Bub1 may exist as a dimer during the normal cell 
cycle, which suggests that the Bub1 dimer have functional roles in cells and potentially explains 
why dimerizing Bub1 leads to spindle checkpoint activation.  
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Introduction  
 For a cell to divide, it needs to carefully duplicate and segregate its chromosomes. The 
chromosomes are first duplicated in synthesis (S) phase. Microtubules then bind to chromosomes 
by attaching to the two sister kinetochores, allowing the chromosomes to congress to the middle 
of the cell (metaphase). The anaphase-promoting complex (APC) and its co-activator Cdc20 
subsequently catalyze the ubiquitination and destruction of securin (Pds1 in budding yeast), 
ultimately triggering chromosome segregation (anaphase). The spindle checkpoint, initially 
identified in the budding yeast [1, 2], prevents chromosome missegregation by allowing entry 
into anaphase only if all chromosomes are bi-oriented (the two sister kinetochores bind 
microtubules from opposite spindle poles) (reviewed in [3, 4]). The kinetochore is required to 
signal to the spindle checkpoint in the presence of attachment errors, potentially by recruiting 
spindle checkpoint proteins and allowing the formation of inhibitory checkpoint complexes (the 
“kinetochore scaffold” model, discussed in Chapter One).  
 We developed a system to test the effect of recruiting checkpoint proteins to DNA by 
using the binding of the lactose repressor (LacI) to the lactose operator (LacO). We showed that 
cells carrying LacO repeats arrest in metaphase when they express Bub1-LacI (described in 
Chapter Two), which suggests that recruiting Bub1 to the chromosome is able to activate the 
spindle checkpoint. It turned out that cells expressing Bub1-LacI arrest even in the absence of 
LacO DNA, indicating that the binding of Bub1 to the chromosome is not required to induce cell 
cycle arrest.  
 We decided to look at the effect of Bub1-LacI more carefully. We show that the 
metaphase arrest in cells expressing Bub1-LacI is caused by dimerization of Bub1 when it is 
fused to LacI. Supporting this idea, expressing other forms of dimerized Bub1 leads to a similar 
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cell cycle arrest. The arrest by the Bub1 dimer depends on the presence of most other checkpoint 
proteins, which suggests that it is acting upstream in the spindle checkpoint pathway. Expression 
of Bub1-LacI affects chromosome bi-orientation in cells, but the Bub1 dimer can induce 
metaphase arrest independently of functional kinetochores, indicating that the mechanism of 
checkpoint activation by the Bub1 dimer is complicated. In addition, we show that Bub1 forms 
dimers in the unperturbed cell cycle independently of other checkpoint proteins, which agrees 
with the idea that the Bub1 dimer contributes to the initiation of the spindle checkpoint.  
 
Results  
Expressing the Bub1 Dimer Arrests Cells in Metaphase 
 Previous experiments showed that cells expressing Bub1-LacI (Bub1 fused to the N 
terminus of lactose repressor) at a low level (from the HIS3 promoter) arrested in metaphase 
even in the absence of LacO repeats (described in Chapter Two). Expression of Bub1-LacI 
therefore somehow induces spindle checkpoint activation. To determine the effect of Bub1-LacI, 
we asked what would happen if we overexpressed Bub1-LacI from the GAL1 promoter in 
budding yeast cells going through a synchronous cell cycle. We integrated a PGAL1-BUB1-LacI 
construct into the yeast genome without modifying the endogenous BUB1 gene. Genes under the 
GAL1 promoter are expressed in the presence of galactose and inhibited by glucose. We arrested 
the cells in G1 with !-factor and released them into media with either glucose or galactose. We 
then looked at the cells three hours later. Cells that are going through the cell cycle normally 
have no bud or buds that are smaller than the mother cell, whereas cells that are delayed in 
mitosis are enlarged and have huge buds that approach the size of the mother cells. 
Overexpressing Bub1 had little effect on the cells; almost the entire population continued to 
 
 
! 43 
cycle when grown in galactose-containing medium (Figure 3-1A). In contrast, overexpressing 
Bub1-LacI led to accumulation of large budded cells (Figure 3-1A), confirming that expression 
of Bub1-LacI alone can induce checkpoint activation.  
 We verified that expressing Bub1-LacI activates the spindle checkpoint and inhibits APC 
activity by using a biochemical marker for the exit into anaphase. Degradation of the APCCdc20  
substrate securin (named Pds1 in budding yeast) triggers the metaphase-to-anaphase transition. 
We followed the level of this protein by monitoring the level of Myc-tagged securin (Pds1-
18!Myc) on Western Blots. When Bub1-LacI was not expressed (glucose), securin levels rose 
and fell after cells were released from G1 arrest, indicating normal cell cycle progression (Figure 
3-1B). Overexpressing Bub1-LacI (galactose) stabilized securin (Figure 3-1B), showing that 
APC activity is inhibited. 
 Bub1-LacI can bind DNA non-specifically even in the absence of LacO repeats, and the 
binding may contribute to checkpoint activation by concentrating Bub1 proteins. To test the 
requirement for DNA binding, we fused Bub1 to a version of LacI without the N-terminal DNA 
binding region but retains the dimerization domain (Bub1-LacI("1-60)) [5]. Expression of Bub1-
LacI("1-60) under the GAL1 promoter in synchronized yeast cells again induced metaphase 
arrest and around 50% of the cells became large budded (Figure 3-1A). The DNA binding 
activity of LacI is thus not required for checkpoint activation by Bub1-LacI.  
 Another possible effect of fusing Bub1 to LacI is that Bub1-LacI should exist as a dimer 
through the dimerization domain of LacI. Expression of the Bub1 dimer may be sufficient to 
arrest cells in metaphase. To test this hypothesis, we generated a covalent Bub1-Bub1 dimer 
construct with the C terminus of Bub1 fused to the N terminus of another Bub1 by a 36-amino 
acid linker. Around 40% of the cells expressing Bub1-Bub1 accumulated in the large budded  
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Figure 3-1. Expressing the Bub1 dimer arrests cells in metaphase. (A) Cells with the indicated PGAL1-
driven genes were grown to mid-log phase, arrested in G1 with !-factor, and were released into media 
with either glucose or galactose. After 3 hours of growth, the percentage of large budded cells was 
determined by light microscopy as a measure of metaphase arrest. Error bars represent the standard 
deviation of three independent trials. Two hundred cells were counted for each trial. (B) Cell cycle 
progression of PGAL1-BUB1-LacI cells was monitored by Western blots (n=3), which detect securin 
(Pds1), a protein that is destroyed as cells enter anaphase. Cells were grown to mid-log phase and arrested 
in G1 with !-factor, and were released into media with either glucose (top) or galactose (bottom). At 60 
min after release from G1 arrest, !-factor was added to prevent cells from progressing into the next S 
phase. Lysates were prepared from cells harvested at the indicated time and Western blots against Myc (to 
visualize Myc-tagged securin) or actin (loading control) were performed. When the cells were grown in 
glucose, securin level first increased and then dropped rapidly as cells progressed into anaphase. When 
Bub1-LacI is expressed in the presence of galactose, securin was stabilized, indicating that the cells were 
arrested in metaphase.  
  
 
 
! 45 
state (Figure 3-1A), supporting the idea that the Bub1 dimer can induce checkpoint activation. 
We also used a different, non-covalent method to dimerize Bub1. We fused Bub1 to two 
engineered leucine zipper sequences (EEzip and RRzip) that allow the formation of stable dimers 
between the two zippers bearing opposing charges [6]. When we expressed the Bub1 dimer (by 
releasing cells containing both PGAL1-Bub1-EEzip and PGAL1-Bub1-RRzip into galactose-
containing medium), 90% of the cells arrested in metaphase (Figure 3-1A). Dimerizing Bub1 
can thus activate the spindle checkpoint in cells. 
 
Checkpoint Activation by the Bub1 Dimer is Independent of the Kinase and Bub3-binding 
Domains of Bub1 
 Bub1 is a protein kinase that has multiple roles in cells. It contains three main regions: a 
highly conserved N-terminal region that is important for its kinetochore targeting [7, 8]; a Gle2-
binding sequence (GLEBS) domain that is required for Bub3 binding [9]; and a C-terminal 
region that contains a serine/threonine kinase domain (Figure 3-2A). Bub1 is essential for the 
spindle checkpoint as well as correct partitioning of chromosomes. It has been suggested that 
Bub1 phosphorylates histone 2A to localize Sgo1, a protein important for chromosome bi-
orientation, to the centromere [10-12]. The kinase domain of Bub1 is essential for its role in 
establishing chromosome bi-orientation but is dispensable for checkpoint function [10-12]. 
Consistent with this claim, we found that expressing LacI fused to a version of Bub1 that lacks 
its kinase domain (bub1!K-LacI) can still induce metaphase arrest in cells, showing that the 
kinase domain of Bub1 is not required for checkpoint activation by the Bub1 dimer (Figure 3-
2B). 
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Figure 3-2. Metaphase arrest by the Bub1 dimer requires the N-terminal region but not the kinase or the 
Bub3-binding domain. (A) Domain organization of Bub1. Bub1 contains a highly conserved N-terminal 
region that is important for its targeting to the kinetochore. It also has a Bub3-binding region (GLEBS 
domain) and a C-terminal kinase domain. (B) Cells with the indicated PGAL1-driven genes were grown to 
mid-log phase, arrested in G1 with !-factor, and were released into media with either glucose or galactose. 
After 3 hours of growth, the percentage of large budded cells was determined by light microscopy as a 
measure of metaphase arrest. bub1!K is a truncated version of Bub1 without the C-terminal kinase 
domain (containing amino acids 1-608). bub1!GLEBS and bub1!N are versions of Bub1 with deletion of 
amino acids 315-350 and 32-140, respectively. Error bars represent the standard deviation of three 
independent trials. Two hundred cells were counted for each trial. 
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 We also determined whether other domains of Bub1 are needed for the metaphase arrest 
by the Bub1 dimer. More than 90% of cells expressing LacI fused to Bub1 without the GLEBS 
domain (bub1!GLEBS-LacI) arrested in metaphase, suggesting that the physical interaction 
between Bub1 and Bub3 is not essential for the Bub1 dimer to activate the checkpoint (Figure 3-
2B). This result agrees with the finding that the GLEBS motif in Bub1 is dispensable for 
checkpoint function in fission yeast [13]. On the other hand, removing the N-terminal region 
from Bub1 (bub1!N-LacI) completely abolished checkpoint activation (Figure 3-2B), which 
indicates that the kinetochore-targeting domain plays an important role in arresting cells in 
metaphase.  
 
The Bub1 Dimer Requires Most Spindle Checkpoint Proteins to Induce Metaphase Arrest 
 We then asked whether the Bub1 dimer needs other checkpoint components to arrest cells 
in metaphase. We introduced the PGAL1-BUB1-LacI construct into yeast strains with different 
spindle checkpoint genes deleted (mad1!, mad2!, mad3!, bub1!, and bub3!) and tested the 
effect of expressing Bub1-LacI by releasing the cells from G1 arrest into galactose-containing 
medium. In all the strains except bub1!, cells failed to activate the checkpoint and were cycling 
normally (Figure 3-3). The results show that the Bub1 dimer requires other spindle checkpoint 
protein (but not endogenous Bub1) for checkpoint activation.  
 We also tested the requirement for two spindle checkpoint kinases, Mps1 and Ipl1, which 
have other essential roles in cells. Mps1 is important for the spindle checkpoint as well as the 
duplication of the spindle pole bodies (SPBs) and mitotic spindle assembly [14, 15]. Ipl1/Aurora 
B is required to activate the spindle checkpoint in the absence of mechanical tension at the 
kinetochores [16, 17]; it is also involved other process such as spindle disassembly [18]. Since  
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Figure 3-3. Checkpoint activation by Bub1-LacI requires most checkpoint components. Cells with PGAL1-
BUB1-LacI and deletion of the indicated checkpoint genes were released from G1 arrest into glucose- or 
galactose-containing media. The percentage of large budded cells was determined by light microscopy 
after 3 hours of growth. Error bars represent the standard deviation of three independent trials. Two 
hundred cells were counted for each trial.  
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both Mps1 and Ipl1 are essential for cell viability, we used conditional alleles to inhibit their 
activities to ask whether they are required for Bub1-LacI to arrest cells. For Mps1, we used the 
analog-sensitive allele mps1-as1 [15], which can be specifically inhibited by a bulky protein 
kinase inhibitor [19]. We released mps1-as1 cells carrying PGAL1-BUB1-LacI from G1 arrest into 
media with or without the kinase inhibitor (1NM-PP1) and monitored securin levels. Cells 
treated with the inhibitor that were grown in glucose-containing medium (to inhibit expression of 
Bub1-LacI) with benomyl and nocodazole (to depolymerize microtubules) showed a rise and fall 
in securin (Figure 3-4A). This result confirms that Mps1-as1 cannot function and the spindle 
checkpoint is abolished in the presence of the inhibitor. Cells that were grown in galactose-
containing medium (to express Bub1-LacI) also showed a similar rise and fall in securin level 
(Figure 3-4A), indicating that inactivation of Mps1 activity prevents metaphase arrest by Bub1-
LacI. We performed similar experiments to test the requirement for Ipl1 by using the analog-
sensitive allele, ipl1-as5 [17]. We released ipl1-as5 cells carrying PGAL1-BUB1-LacI from G1 
arrest into media with or without a different inhibitor (1NA-PP1). Expressing Bub1-LacI 
stabilized securin even when Ipl1 was inactivated by the inhibitor (Figure 3-4B), indicating that 
Ipl1 function is not necessary for metaphase arrest by the Bub1 dimer. Overall Bub1-LacI 
requires most checkpoint proteins to activate the spindle checkpoint, suggesting that it exerts its 
effect upstream in the checkpoint pathway.  
 
Expression of the Bub1 Dimer Affects Chromosome Bi-orientation 
 Why does the Bub1 dimer arrest cells in metaphase? One possible explanation is that 
expression of the Bub1 dimer somehow affects microtubule attachments to chromosomes, and 
the defects in turn activate the spindle checkpoint. We therefore looked at chromosome bi-  
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Figure 3-4. Spindle checkpoint activation by Bub1-LacI requires Mps1 but not Ipl1 function. (A) Cell 
cycle progression of cells with PGAL1-BUB1-LacI and mps1-as1 was monitored by Western blotting (n=3). 
Cells were released from G1 arrest into media with either glucose with benomyl and nocodazole (top) or 
galactose (bottom), in the absence (-Inhibitor) or presence (+Inhibitor) of 1NM-PP1, an inhibitor of the 
analog-sensitive Mps1. At 60 min after release from G1 arrest, !-factor was added to prevent cells from 
progressing into the next S phase. Lysates were prepared from cells harvested at the indicated time and 
Western blots against Myc or actin (loading control) were performed. Both securin and Mps1-as1 are 
tagged with Myc in the strain, and only the bands corresponding to Myc-tagged securin are shown in the 
figure. Securin level increased and then dropped in galactose-containing medium in the presence of 
inhibitor, indicating that Mps1 activity is needed for the metaphase arrest. (B) The cell cycle progression 
of cells with PGAL1-BUB1-LacI and ipl1-as5 was measured by Western blots (n=3). Cells were released 
from G1 arrest into media with either glucose (top) or galactose (bottom), in the absence (-Inhibitor) or 
presence (+Inhibitor) of 1NA-PP1, an inhibitor of the analog-sensitive Ipl1. At 60 min after release from 
G1 arrest, !-factor was added to prevent cells from progressing into the next S phase. Lysates were 
prepared from cells harvested at the indicated time and Western blots against Myc (to visualize Myc-
tagged securin) or actin (loading control) were performed. Securin was stabilized in galactose-containing 
medium in the presence of inhibitor, showing that Ipl1 activity is not needed for the metaphase arrest. 
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orientation in cells at metaphase. A chromosome is bi-oriented when the two sister kinetochores 
attach to microtubules from opposite spindle poles. The sister kinetochores can be pulled apart 
from each other by the microtubules, and we can visualize the separation (about 0.5 µm) by 
expressing a GFP-LacI and placing a LacO array near the centromere [20-23]. We integrated 
different Bub1 constructs under the GAL1 promoter into a strain that expresses GFP-LacI, has a 
LacO array near the centromere of chromosome XV, and CDC20 under the methionine-
repressible MET3 promoter (PMET3-CDC20). We grew the cells in medium with galactose (to 
express the Bub1 construct) and methionine (to inhibit Cdc20 expression). The cells arrested in 
metaphase because they cannot activate the APC in the absence of Cdc20. Around 80% of the 
cells expressing Bub1 in this case showed two GFP dots, indicating that chromosome XV bi-
oriented (Figure 3-5). The percentage of cells with two GFP dots was much lower (around 15%) 
when cells expressed Bub1-LacI instead (Figure 3-5). Chromosomes bi-orientation is thus 
affected by Bub1-LacI, showing that the Bub1 dimer potentially activates the spindle checkpoint 
by creating mono-oriented chromosomes.  
 Bub1 localizes at kinetochores and is important for chromosome bi-orientation, for 
example by phosphorylating histone 2A and recruiting Sgo1 to the centromere [10-12]. The 
kinase activity and kinetochore localization of Bub1 is essential for its role in establishing bi-
oriented chromosomes. We speculate that when the Bub1 dimer is expressed at a high level, a 
portion of the dimers fail to localize to the kinetochore. The mislocalized Bub1 dimers may 
interfere with chromosome bi-orientation by sequestering downstream targets away from Bub1 
at the kinetochore. Cells that were arrested in metaphase by Cdc20 depletion had an even 
stronger defect in chromosome bi-orientation when they expressed bub1!K-LacI (Figure 3-5). 
One explanation is that in addition to binding to Bub1 targets and keeping them away from the 
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Figure 3-5. Expression of Bub1-LacI affects chromosome bi-orientation. To achieve metaphase arrest, 
cells carrying the indicated PGAL1-driven genes, GFP-LacI, a LacO array located near the centromere of 
chromosome XV, and PMET3-CDC20 were released from G1 arrest into medium with galactose (to express 
the checkpoint construct) and methionine (to inhibit Cdc20 expression). Differential interference contrast 
(DIC) and GFP images of the cells were taken 3 hours after their release from G1. One or two GFP dots 
can be seen in cells arrested in metaphase. Cells have two GFP dots when chromosome XV bi-orients and 
the two sister kinetochores are separated by the spindle. Cells have one GFP dot when chromosome XV 
mono-orients (sister kinetochores attaching to the same spindle pole) or bi-orients but the two sister 
kinetochores are not pulled apart enough to allow resolution of two separate dots. Representative images 
of metaphase-arrested cells with one or two GFP dots are shown (Scale bar, 5 µm). The bar graph shows 
the percentage of cells with one or two GFP dots when they were arrested by Cdc20 depletion. Error bars 
represent the standard deviation of three independent trials. Two hundred cells were counted for each 
trial. Around 80% of the cells expressing Bub1 had two GFP dots. The percentages of cells that showed 
two GFP dots when Bub1-LacI or bub1!K-LacI was expressed were much lower. Chromosome bi-
orientation (or the ability to apply force to bioriented chromosomes) is therefore compromised in cells 
expressing the Bub1 dimer.  
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kinetochore, Bub1-LacI and bub1!K-LacI also replace the endogenous Bub1 at the kinetochore. 
While Bub1-LacI can perform the functions of Bub1 at the kinetochore, bub1!K-LacI is unable 
to support chromosome bi-orientation because it lacks kinase activity. Expressing bub1!K-LacI 
in cells thus induces a stronger bi-orientation defect. 
 
Metaphase Arrest by the Bub1 Dimer Does Not Require Functional Kinetochores 
 The presence of functional kinetochores is required to signal to the spindle checkpoint in 
response to microtubule attachment defects [24, 25]. Metaphase arrest by the Bub1 dimer should 
depend on kinetochore functions if the Bub1 dimer activates the checkpoint solely by disrupting 
chromosome bi-orientation. We looked at the phenotype of Bub1-LacI expression in the absence 
of functional kinetochores by using an ndc10-1 strain. Ndc10 is a member of the CBF3 complex 
of the kinetochore, which binds to the centromere and serves as the primary link between the 
chromosome and microtubule binding complexes of the kinetochore [26]. ndc10-1 cells lack 
functional kinetochores at the restrictive temperature (37oC) and are unable to activate the 
spindle checkpoint even in the presence of the microtubule deploymerizing drugs benomyl and 
nocodazole [24, 25]. If the Bub1 dimer activates the checkpoint by interfering with chromosome 
bi-orientation, we should not observe metaphase arrest when Bub1-LacI is expressed in ndc10-1 
cells at 37oC. To test this prediction, we released ndc10-1 cells carrying PGAL1-BUB1-LacI from a 
G1 arrest at 25oC or 37oC and monitored the level of securin. In cells that were released into 
glucose-containing medium (to inhibit expression of Bub1-LacI) with benomyl and nocodazole 
(to depolymerize microtubules) at 37oC, securin levels rose and fell, showing that cells failed to 
activate the spindle checkpoint in the absence of functional kinetochores (Figure 3-6). In 
contrast, when ndc10-1 cells expressed Bub1-LacI (by releasing them into galactose-containing  
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Figure 3-6. The metaphase arrest by Bub1-LacI does not require functional kinetochores. Cell cycle 
progression of cells with PGAL1-BUB1-LacI and ndc10-1 (a mutation that inactivates kinetochore at 37˚C) 
was measured by Western blots (n=3). Cells were released from G1 arrest into media with either glucose 
with benomyl and nocodazole (top) or galactose (bottom) at 25oC or 37oC. At 60 min after release from 
G1 arrest, !-factor was added to prevent cells from progressing into the next S phase. Lysates were 
prepared from cells harvested at the indicated time and Western blots against Myc (to visualize Myc-
tagged securin) or actin (loading control) were performed. Securin was stabilized in galactose-containing 
medium even at 37oC, indicating that the metaphase arrest by Bub1-LacI is independent of functional 
kinetochores.  
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medium) at 37oC, securin was stabilized (Figure 3-6). Similar results were observed in ndc10-1 
cells expressing bub1!K-LacI (data not shown). The Bub1 dimer can thus arrest cells in 
metaphase even in the absence of functional kinetochores, suggesting that it is able to activate 
the checkpoint independently of its effect on chromosome bi-orientation.  
 
A High Level of Mad3 Interferes with Metaphase Arrest by the Bub1 Dimer  
 To determine what checkpoint proteins the Bub1 dimer may interact with, we expressed 
other checkpoint components with Bub1-LacI to see how they affected the level of checkpoint 
activation. Overexpressing Mad3 together with Bub1-LacI led to a weaker metaphase arrest than 
expressing Bub1-LacI alone, suggesting that Mad3 interferes with the ability of Bub1-LacI to 
activate the checkpoint (Figure 3-7A). Both Bub1 and Mad3 contain a conserved Gle2-binding 
sequence (GLEBS) motif which bind the same surface of Bub3 in a mutually exclusive manner 
[9, 27, 28]. A high concentration of Mad3 may act as a competitive inhibitor and sequester Bub3 
away from the Bub1 dimer, therefore affecting the extent of checkpoint activation. Although the 
interaction between Bub1 and Bub3 is thought to be important for the spindle checkpoint, 
expressing LacI fused to Bub1 without the GLEBS motif (bub1!GLEBS-LacI) still arrested cells 
in metaphase, suggesting that the Bub1 dimer can activate the checkpoint without associating 
with Bub3 (Figure 3-2B and Figure 3-7A). Interestingly, the arrest induced by bub1!GLEBS-
LacI was not affected by Mad3 expression (Figure 3-7A). While certain checkpoint proteins like 
Mad3 are required for metaphase arrest by bub1!GLEBS-LacI, a moderate percentage of cells 
expressing bub1!GLEBS-LacI arrested even in the absence of Bub3 (Figure 3-7B). One possible 
explanation for these results is that the GLEBS domain normally inhibits the checkpoint function 
of Bub1, for example by physically blocking the surface for substrate binding. The binding of  
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Figure 3-7.  Checkpoint activation by the Bub1 dimer is affected by a high concentration of Mad3 in a 
Bub3-binding motif dependent manner. (A) Cells with the indicated PGAL1-driven genes were released 
from G1 arrest into glucose- or galactose-containing media. The percentage of large budded cells was 
determined by light microscopy after 3 hours of growth. Error bars represent the standard deviation of 
three independent trials. Two hundred cells were counted for each trial. (B) Cells with PGAL1-
bub1!GLEBS-LacI and deletion of the indicated checkpoint genes were released from G1 arrest into 
glucose- or galactose-containing media. The percentage of large budded cells was determined by light 
microscopy after 3 hours of growth. Error bars represent the standard deviation of three independent 
trials. Two hundred cells were counted for each trial. 
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Bub3 to the GLEBS domain may move the motif away from Bub1, therefore relieving the 
inhibition and activating the checkpoint function of Bub1. A high concentration of Mad3 
sequesters Bub3 and interferes with this process, which explains why overexpressing Mad3 
affects the checkpoint activation by the Bub1 dimer. On the other hand, Bub1 is no longer 
inhibited by the GLEBS domain when the motif is deleted. Bub3 is dispensable for stimulating 
the checkpoint function of Bub1 in this case. bub1!GLEBS-LacI can thus arrest cells in 
metaphase independently of Bub3 and the arrest is not affected by a high level of Mad3. It will 
be interesting to test whether this model is true by further investigating how Mad3, Bub1, and 
Bub3 coordinate with each other during checkpoint activation.   
 
Bub1 Interacts with Itself During the Yeast Cell Cycle 
 Dimerization of Bub1 might occur during the cell cycle as an essential step in spindle 
checkpoint activation. If so, the expression of the artificial Bub1 dimer simply recapitulates this 
event and hence activates the checkpoint. Bub1 associates with both Bub3 and Mad1 [29, 30], 
but it is not clear whether Bub1 also interacts with itself. To look for potential Bub1 dimer, we 
constructed diploid strains that carry Myc-tagged (Bub1-13!Myc) and FLAG-tagged Bub1 
(Bub1-3!FLAG) under the GAL1 promoter and performed coimmunoprecipitation (co-IP) 
experiments. We grew the cells in media with galactose (to express the Bub1 constructs) either 
with or without the microtubule deploymerizing drugs benomyl and nocodazole for three hours. 
We expressed the two epitope-tagged versions of Bub1 (which do not have a dimerization 
domain) under the GAL1 promoter because it led to strong signals on Western blots and had no 
effect on cell cycle progression (data not shown). We then prepared lysates from the cultures for 
co-IP. An anti-FLAG immunoprecipitate from an asynchronous culture (no benomyl and 
 
 
! 58 
nocodazole) contained a low level Bub1-13!Myc in addition to Bub1-3!FLAG, indicating that 
Bub1 can associate with itself and potentially form a dimer (Figure 3-8A). The low level of 
Bub1-13!Myc in the immunoprecipitates suggests that the interaction only involves a fraction of 
the total Bub1 in the cells. Arresting cells in metaphase by benomyl and nocodazole had no 
obvious effect on the level of Bub1-13!Myc in the anti-FLAG immunoprecipitate (Figure 3-
8A), which shows that the Bub1-Bub1 interaction is not cell cycle regulated and is largely 
unaffected by activation of the spindle checkpoint. An anti-Myc immunoprecipitate from the 
same strain contained Bub1-3!FLAG as well as Bub1-13!Myc (Figure 3-8A), confirming that 
Bub1 proteins are able to interact with each other.  
 We noticed that the mobility of Bub1-13!Myc and Bub1-3!FLAG in the anti-FLAG 
immunoprecipitates was sometimes slower when compared to that in the total lysates (Figure 3-
8A). This was not observed in the anti-Myc immunoprecipitates. Treating the anti-FLAG 
immunoprecipitates with phosphatase had no effect on the migration of the bands (data not 
shown), indicating that the change in mobility is not due to phosphorylation. We believe the shift 
is simply an artifact of co-IP experiments with anti-FLAG antibodies.  
 We then asked whether the Bub1-Bub1 interaction requires the presence of other 
checkpoint proteins. We introduced PGAL1-BUB1-3!FLAG and PGAL1-BUB1-13!Myc into 
diploid yeast strains with both copies of different spindle checkpoint genes deleted (mad1", 
mad2", mad3", bub1", and bub3") and repeated the co-IP experiments. In all cases, both Bub1-
3!FLAG and Bub1-13!Myc were found in the anti-FLAG immunoprecipitates, indicating that 
the interaction between two Bub1 proteins is independent of the presence of other components of 
the checkpoint (Figure 3-8B). Our results suggest that the Bub1-Bub1 interaction is constitutive 
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Figure 3-8. Bub1 can interact with itself during normal cell cycle.  (A) Diploids cells were grown in 
galactose-containing media (to express the indicated epitope-tagged Bub1) in the absence or presence 
(+Ben&Noc) of benomyl and nocodazole for 3 hours before lysates were made. Either Bub1-3!FLAG 
(IP: anti-FLAG) or Bub1-13!Myc (IP: anti-Myc) was then immunoprecipitated. The immunoprecipitates 
(IP) and the total lysates (Total) were used for Western blots (WB) with anti-Myc (to visualize Bub1-
13!Myc) and anti-FLAG (to visualize Bub1-3!FLAG) antibodies (n=3). When Bub1-13!Myc and Bub1-
3!FLAG were expressed in the same cells, both epitope-tagged Bub1 were found in the 
immunoprecipitates, showing that Bub1 can potentially form dimers. Association between the two Bub1 
proteins was observed in both cycling cells and cells arrested metaphase, suggesting that the interaction is 
cell cycle independent. (B) The Bub1-Bub1 interaction does not require other checkpoint proteins. 
Diploids cells carrying PGAL1-BUB1-3!FLAG and PGAL1-BUB1-13!Myc and deletion of the indicated 
checkpoint genes were grown in galactose-containing media (to express the epitope-tagged Bub1) for 3 
hours before extracts were made and Bub1-3!FLAG (IP: anti-FLAG) was immunoprecipitated. The 
immunoprecipitates (IP) and the total lysates (Total) were then used for Western blots (WB) with anti-
Myc (to visualize Bub1-13!Myc) and anti-FLAG (to visualize Bub1-3!FLAG) antibodies (n=3). In all 
cases both Bub1-13!Myc and Bub1-3!FLAG were found in the immunoprecipitates, showing that other 
spindle checkpoint proteins are not required for the interaction.  
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and may act as an upstream component in the spindle checkpoint pathway.  
 
Conclusions and Discussion 
 We found that expressing the Bub1 dimer leads to metaphase arrest and spindle 
checkpoint activation in cells. Three different dimerization methods produced the same result, 
arguing that dimer formation, rather than a particular mechanism of dimerization, activates the 
checkpoint. The phenotype is independent of the kinase and Bub3-binding domains of Bub1 but 
requires the N-terminal kinetochore-targeting region. The metaphase arrest depends on the 
presence of most other checkpoint proteins, suggesting that the Bub1 dimer is acting upstream in 
the spindle checkpoint pathway. Chromosome bi-orientation is compromised in cells expressing 
Bub1-LacI, but the Bub1 dimer is able to arrest cells even in the absence of functional 
kinetochores, showing that the Bub1 dimer may activate the spindle checkpoint through multiple 
mechanisms. We found that Bub1 may form dimers during normal cell cycle independently of 
other checkpoint components, which suggests that the Bub1 dimer has functional roles in cells, 
such as initiating the spindle checkpoint. 
 The major finding from our experiments is that expressing the Bub1 dimer activates the 
spindle checkpoint. Overexpressing wild type Bub1 in budding yeast increases the rate of 
chromosome loss but has little effect on cell cycle progression [31], suggesting that the cell cycle 
arrest is induced by Bub1 dimerization rather than simply a high cellular level of Bub1 protein. 
We found that wild-type Bub1 may form dimers in cells, supporting the idea that the Bub1 dimer 
has a role in the spindle checkpoint. One possibility is that dimerization of Bub1 is important for 
its interaction with Mad1. During checkpoint activation, Mad1 dimerizes and recruits Mad2 to 
form a tetrameric 2:2 complex at the kinetochores [32-34]. It is not clear how Mad1 is localized 
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to the kinetochore. Bub1 associates with Mad1 in budding yeast, and the interaction only occurs 
when the spindle checkpoint is activated, suggesting that the binding is an important step in the 
checkpoint pathway [30]. A potential model is that Bub1 dimerizes at the kinetochore, and this 
dimer in turn binds a dimer of Mad1. This interaction may facilitate the localization and 
activation of Mad1, ultimately leading to the formation of Mad1-Mad2 complex at the 
kinetochore and spindle checkpoint activation. 
 When we overexpressed monomeric Bub1 in cells, only a fraction of them interacted with 
each other. One explanation is that Bub1 dimerizes strongly only when it is localized at the 
kinetochore. Since our results show that the Bub1 dimer can be found throughout the cell cycle, 
it will be necessary to regulate the interaction between Mad1 and Bub1 at the kinetochore if their 
association is important for checkpoint activation. Several mechanisms may help prevent the 
binding of the Bub1 dimer to Mad1 in the presence of proper microtubule attachments. 
Microtubule binding to the kinetochore may sterically block the interaction of Mad1 with Bub1 
because the microtubule is in close proximity to Bub1 and leaves no room for Mad1 binding. It is 
also possible that microtubule binding leads to structural changes or post-translational 
modifications in Bub1 that prevent Mad1 binding. We speculate that when the artificial Bub1 
dimer is overexpressed, a portion of the dimers can be found away from the kinetochore and thus 
escapes the inhibition. The dimers then directly lead to ectopic checkpoint activation, for 
example by inducing the production of Mad1-Mad2 complexes. If localization of the dimer away 
from the kinetochore leads to checkpoint activation, it would explain why the artificial Bub1 
dimer activates the spindle checkpoint and arrests cells while the small quantities of Bub1 dimer 
found in cells expressing monmeric Bub1 fail to arrest the cell cycle. More experiments will be 
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needed to look at the interaction between Mad1 and the Bub1 dimer and determine whether the 
binding of Mad1 to Bub1 represents an important step in checkpoint activation.  
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Materials and Methods 
Yeast Strains and Methods 
 All strains are derivatives of W303 (ade2-1  his3-11,15  leu2-3,112  trp1-1  ura3-1  can1-
100), and are listed in Table 3-1. Strains were constructed using standard genetic techniques. All 
media were prepared using established recipes [35], and contain 2% wt/vol of the indicated sugar 
as the carbon source. To prepare media containing benomyl and nocodazole, DMSO stocks of 
methyl 1-(butylcarbamoyl)-2-benzimidazolecarbamate (benomyl) (Sigma-Aldrich, St. Louis, 
MO) and nocodazole (Sigma-Aldrich, St. Louis MO) were added to yeast extract and peptone 
(YEP) with 2% wt/vol glucose to a final concentration of 30µg/ml of each drug.  
 
Cell Cycle Analysis by Light Microscopy 
 To look at the effect of overexpressing different Bub1 constructs on cell cycle 
progression, cells were first grown to mid-log phase (107 cells/ml) in YEP with 2% raffinose 
(wt/vol). Cells were then arrested in G1 by adding 10µg/ml !-factor (Bio-Synthesis, Lewisville, 
TX) and incubated for 2 hours at 30oC. Cells were washed four times to remove !-factor and 
resuspended in YEP with either 2% glucose (wt/vol) or 2% galactose (wt/vol). After growing for 
3 hours at 30oC, the cultures were briefly sonicated to separate cells that fail to dissociate 
completely after division and the percentage of large-budded cells in each sample was 
determined by light microscopy.  
 
Cell Cycle Analysis by Western Blots 
 To monitor cell cycle progression by Western blots, cells were grown and arrested in G1 
as described above, and released into the indicated media. 1µg/ml !-factor was used for bar1! 
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strains. For experiments with ndc10-1 strains, cells were grown to mid-log phase (107 cells/ml) in 
YEP with 2% raffinose (wt/vol) at 25oC. Cells were then arrested in G1 by adding 10µg/ml !-
factor and incubated for 2 hours at 25oC, and shifted to 37oC for 30 min to inactivate ndc10-1. 
Cells were washed four times to remove !-factor and resuspended in the indicated media at 
37oC. In all Western blot experiments, 10µg/ml !-factor was added at 60 min after release from 
G1 arrest to prevent cells from progressing into the next S phase. 
 For experiments with mps1-as1 strains, DMSO (-Inhibitor) or 10µM of 1NM-PP1 
(+Inhibitor) was added to the media after releasing the cells from G1 arrest to inhibit the activity 
of Mps1-as1. For experiments with ipl1-as5 strains, DMSO (-Inhibitor) or 50µM of 1NA-PP1 
(+Inhibitor) was added to inhibit the activity of Ipl1-as5.  
 In all Western blot experiments, 1ml samples of the culture were collected at the 
indicated time points, and the cells were pelleted by centrifugation for 1 min at room 
temperature. The supernatant was removed, and cell pellets were stored at -80oC.  
 Cell pellets were lysed using a NaOH/"-mercaptoethanol-based protocol [36]. Proteins 
samples were loaded onto and separated in 10% Criterion Tris-HCl polyacrylamide gel (Bio-
Rad, Hercules, CA). Proteins were transferred overnight to nitrocellulose (Whatman, Picataway, 
NJ). Western blotting for Myc-tagged securin were performed using anti-Myc 9E10 antibodies 
(Roche Applied Science, Indianapolis, IN) at a 1:500 dilution, and actin was detected with anti-
actin antibodies (Abcam, Cambridge, MA) used at a 1:2000 dilution. Horseradish peroxidase-
conjugated goat anti-mouse (Santa Cruz Biotechnology, Santa Cruz, CA) was used as the 
secondary antibody at a 1:2000 dilution. The secondary antibody was detected by SuperSignal 
West Dura Chemiluminescent Substrate (Thermo Fisher Scientific, Rockford, IL) and the blot 
was imaged with an AlphaImager (ProteinSimple, Santa Clara, CA).  
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Fluorescence Microscopy 
 To look at cells arrested in metaphase by live-cell microscopy, cells were synchronized in 
G1 with 1µg/ml !-factor and then subjected to a constant flow of media for 3 hours at room 
temperature using the ONIX microfluidic perfusion platform (CellASIC, Hayward, CA). 
Fluorescence microscopy was performed using Nikon Ti-E inverted microscope (Nikon, 
Melville, NY) equipped with a 60x objective (PlanApo, numerical aperture 1.4, oil), GFP filter 
(Chroma Technology, Bellow Falls, VT), and a CoolSNAP charge-coupled device camera 
(Photometrics, Tucson, AZ). Z-stacks of 25 sections were acquired using exposure times of 350 
ms in Metamorph (Molecular Devices, Sunnyvale, CA). Z-stacks were combined into a single 
maximum intensity projection with ImageJ (NIH).  
 
Co-Immunoprecipitation  
 For immunoprecipitation experiments, cells were first grown to mid-log phase (107 
cells/ml) in 20ml of YEP with 2% raffinose (wt/vol) and resuspended in YEP with 2% galactose 
(wt/vol) for 3 hours. Cells were harvested by brief centrifugation and the pellets were 
immediately frozen with liquid nitrogen. Yeast extracts were made by vortexing frozen cell 
pellets in 200µl of lysis buffer (100mM NaCl, 50mL Tris-HCl pH7.5, 10% glycerol, 50mM NaF, 
50mM Na-"-glycerolphosphate, 2mM EDTA, 0.1% Triton X-100, 1mM Na3VO4, 1mM PMSF, 
protease inhibitor cocktail) and around 100µl of acid washed glass beads for three rounds of one 
minute, incubating on ice for one minute between each round. The resulting lysate was separated 
from the glass beads and centrifuged at 14,000 rpm for five minutes at 4oC to remove insoluble 
material. A portion of the lysate was mixed with an equal volume of 2X SDS sample buffer 
(Total). 
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 Antibody was added to the remaining lysate at 1:50 dilution and incubated on ice for one 
hour. Samples were then transferred to 30µl of Protein A/G PLUS-agarose beads (Santa Cruz 
Biotechnology, Santa Cruz, CA) which had been equilibrated in lysis buffer. The beads were 
rotated at 4oC for one hour. The beads were then washed four times with lysis buffer and boiled 
in SDS sample buffer for ten minutes. The resulting samples (IP) were used for Western blotting 
as described above. Western blotting for Myc-tagged Bub1 was performed using anti-Myc 9E10 
antibodies (Roche Applied Science, Indianapolis, IN) at a 1:500 dilution, and FLAG-tagged 
Bub1 was detected with anti-FLAG antibodies (Sigma-Aldrich, St. Louis, MO) used at a 1:2000 
dilution. 
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Table 3-1. Strains used in this Chapter.  
Strain Name Genotype 
DLY486 MATa  PGAL1-BUB1-LacI@URA3   
DLY488 MATa  PGAL1-BUB1@URA3   
DLY499 MATa  PGAL1-BUB1-LacI@URA3  mad1!::HIS3 
DLY500 MATa  PGAL1-BUB1-LacI@URA3  mad2!::Kanr 
DLY501 MATa  PGAL1-BUB1-LacI@URA3  mad3!::Kanr 
DLY502 MATa  PGAL1-BUB1-LacI@URA3  bub3!::Kanr 
DLY508 MATa  PGAL1-BUB1-LacI@URA3  PDS1::18xMYC::LEU2 
DLY545 MATa  PGAL1-BUB1-LacI@URA3  bub1!::Kanr 
DLY555 MATa  PGAL1-BUB1-LacI(!1-60)@URA3   
DLY564 MATa  PGAL1-bub1!k-LacI@URA3   
DLY589 MATa  PGAL1-BUB1-BUB1@URA3   
DLY958 MATa  PGAL1-bub1!GLEBS-LacI@URA3   
DLY989 MATa  PGAL1-BUB1-EEzip@URA3  PGAL1-BUB1-RRzip@HIS3 
DLY1016 MATa  PGAL1-bub1!GLEBS-LacI@URA3  mad1!::HIS3 
DLY1017 MATa  PGAL1-bub1!GLEBS-LacI@URA3  mad2!::Kanr 
DLY1018 MATa  PGAL1-bub1!GLEBS-LacI@URA3  mad3!::Kanr 
DLY1071 MATa  PGAL1-bub1!GLEBS-LacI@URA3  bub1!::Kanr 
DLY1090 MATa  PGAL1-BUB1-LacI@URA3  PGAL1-MAD3@HIS3 
DLY1091 MATa  PGAL1-bub1!GLEBS-LacI@URA3  PGAL1-MAD3@HIS3 
DLY1117 MATa  PGAL1-BUB1-LacI@URA3  mps1!::Kanr::10"MYC-mps1-as1-TRP1  
PDS1::18"MYC::LEU2 
DLY1118 MATa  PGAL1-BUB1-LacI@URA3  ipl1!::Kanr::ipl1-as5-LEU2  PDS1::18"MYC::LEU2  
bar1! 
DLY1119 MATa  PGAL1-BUB1-LacI@URA3  ndc10-1  PDS1::18"MYC::LEU2 
DLY1131 MATa  PGAL1-bub1!GLEBS-LacI@URA3  bub3!::Kanr 
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Table 3-1 (Continued). Strains used in this Chapter.  
Strain Name Genotype 
DLY1141 MATa  PGAL1-bub1!N-LacI@URA3   
DLY1142 MATa  PGAL1-BUB1-LacI@ADE2  cdc20!:: PMET3-3"HA-CDC20-TRP1  PCUP1-
GFP-LacI@HIS3  LacO256-URA3@CEN15  PDS1::18"MYC::LEU2  bar1! 
DLY1143 MATa  PGAL1-bub1!k-LacI @ADE2  cdc20!:: PMET3-3"HA-CDC20-TRP1  PCUP1-
GFP-LacI@HIS3  LacO256-URA3@CEN15  PDS1::18"MYC::LEU2  bar1! 
DLY1162 MATa/#  PGAL1-BUB1-3"FLAG @URA3/ PGAL1-BUB1-13"MYC@URA3 
DLY1163 MATa/#  PGAL1-BUB1-13"MYC@URA3/ura3-1 
DLY1179 MATa  PGAL1-BUB1 @ADE2  cdc20!:: PMET3-3"HA-CDC20-TRP1  PCUP1-GFP-
LacI@HIS3  LacO256-URA3@CEN15  PDS1::18"MYC::LEU2  bar1! 
DLY1190 MATa/#  PGAL1-BUB1-3"FLAG @URA3/ PGAL1-BUB1-13"MYC@URA3  
mad1!::HIS3/ mad1!::HIS3 
DLY1191 MATa/#  PGAL1-BUB1-3"FLAG @URA3/ PGAL1-BUB1-13"MYC@URA3  
mad2!::Kanr/ mad2!::Kanr 
DLY1192 MATa/#  PGAL1-BUB1-3"FLAG @URA3/ PGAL1-BUB1-13"MYC@URA3  
mad3!::Kanr/ mad3!::Kanr 
DLY1193 MATa/#  PGAL1-BUB1-3"FLAG @URA3/ PGAL1-BUB1-13"MYC@URA3  
bub1!::Kanr/ bub1!::Kanr 
DLY1194 MATa/#  PGAL1-BUB1-3"FLAG @URA3/ PGAL1-BUB1-13"MYC@URA3  
bub3!::Kanr/ bub3!::Kanr 
DLY1197 MATa/#  PGAL1-BUB1-3"FLAG @URA3/ura3-1 
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Abstract 
 The spindle checkpoint ensures accurate chromosome transmission by delaying 
chromosome segregation until all chromosomes are correctly aligned on the mitotic spindle. The 
checkpoint is activated by kinetochores that are not attached to microtubules or are attached but 
not under tension and arrests cells at metaphase by inhibiting the anaphase-promoting complex 
(APC) and its co-activator Cdc20. Despite numerous studies, we still do not understand how the 
checkpoint proteins coordinate with each other to inhibit APCCdc20 activity.  
 Inspired by the effect of expressing the Bub1 dimer, we constructed fusions of checkpoint 
proteins and expressed them in budding yeast to mimic possible protein interactions during 
checkpoint activation. We found that expression of a Mad2-Mad3 protein fusion or non-
covalently linked Mad2 and Mad3, but not the overexpression of the two separate proteins, 
induces metaphase arrest that is independent of functional kinetochores or other checkpoint 
proteins. We further showed that artificially tethering Mad2 to Cdc20 also arrests cells in 
metaphase independently of other checkpoint components. Our results suggest that Mad3 is 
required for the stable binding of Mad2 to Cdc20 in vivo, which is sufficient to inhibit APC 
activity and is the most downstream event in spindle checkpoint activation.  
 
 
 
 
 
This chapter is adapted from Lau, D.T.C., and Murray, A.W. (2012). Mad2 and Mad3 Cooperate 
to Arrest Budding Yeast in Mitosis. Current Biology 22, 180–190   
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Introduction 
 Faithful segregation of genetic material during cell division is essential for the viability of 
all organisms. For each chromosome, DNA replication creates two identical copies, which are 
segregated from each other at mitosis. Segregation is directed by the kinetochore, a specialized 
multi-protein structure that assembles on centromeric DNA and binds to and moves along 
microtubules. Normal segregation depends on the two sister kinetochores attaching to 
microtubules from opposite spindle poles during mitosis. Eukaryotes use a control circuit called 
the spindle checkpoint to ensure accurate segregation. During unperturbed mitosis, an E3 
ubiquitin ligase known as the anaphase-promoting complex (APC) and its co-activator Cdc20 
triggers anaphase and chromosome segregation by catalyzing the ubiquitination and destruction 
of securin (Pds1 in budding yeast) (Figure 4-1A). The absence of microtubule attachment [1, 2] 
or the lack of tension at the kinetochore (because of chromosome failing to attach to opposite 
spindle poles) [3-5] activates the checkpoint, which arrests cells at the metaphase-to-anaphase 
transition by targeting APC and Cdc20 for inhibition (for reviews see [6, 7]). In the budding 
yeast, Saccharomyces cerevisiae, the key players of the spindle checkpoint include Mad1, Mad2, 
Mad3, Bub1, Bub3, Mps1, and Ipl1, all of which are highly conserved among eukaryotes [1, 2, 8, 
9]. 
 Although the checkpoint proteins have been studied extensively, we lack a molecular 
description of how events at the kinetochore are converted into inhibition of the APC. Several 
models have been described including the conformational change (Mad2-template) model [6], 
which proposes that Mad1-Mad2 complexes associate with kinetochores that lack microtubule 
attachments and recruit an “open” Mad2 conformer (O-Mad2), facilitating the formation of the 
“closed” Mad2 (C-Mad2)-Cdc20 complex (Figure 4-1B). Besides the recruitment of Mad1 and 
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Figure 4-1. A model for spindle checkpoint. (A) During mitosis, when all chromosomes are properly 
attached to microtubules, the anaphase-promoting complex (APC) and its co-activator Cdc20 
polyubiquitinate different substrates such as securin (Pds1 in budding yeast), leading to its destruction and 
anaphase onset. (B) The spindle checkpoint is activated by the absence of microtubule attachment or the 
lack of tension at the kinetochore. Mad1-Mad2 complexes associate with unattached kinetochores and 
recruit the “open” Mad2 conformer (O-Mad2), facilitating the formation of a “closed” Mad2 (C-Mad2)-
Cdc20 complex. The closed Mad2-Cdc20 complex associates with Mad3 and Bub3, which can be 
recruited to the kinetochores by interactions with Bub1 (not shown), to form the mitotic checkpoint 
complex (MCC).  Inhibition of APC activity by the MCC arrests the cells in metaphase and gives the cells 
time to correct attachment errors at the kinetochores.
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Mad2 to unattached kinetochores, experiments such as fluorescent protein localization and 
coimmunoprecipitation (co-IP) have shown that in budding yeast both Bub1 and Bub3 can 
associate with kinetochore [10] and Mad1 [11], while Mad3 can interact with both Mad2 and 
Bub3 [12]. This complicated network of interactions can potentially bring different checkpoint 
proteins together at the kinetochores in response to attachment errors and lead to formation of 
additional inhibitory complexes. One example is the mitotic checkpoint complex (MCC), which 
is proposed to consist of Mad2, Mad3, Bub3 and Cdc20 and has been shown to be a potent 
inhibitor of APCCdc20  [13, 14] (Figure 4-1B).  Inhibition of APC activity arrests cells in 
metaphase and provides the cells a chance to correct the attachment errors at the kinetochores. 
The spindle checkpoint hence ensures that cells only progress through mitosis when all 
chromosomes are properly attached.   
 The initial studies that identified Cdc20 as the target of the spindle checkpoint showed 
that both Mad2 and Mad3 bind to Cdc20 [15]. We have investigated the consequences of this 
binding by manipulating the linkage between Mad2, Mad3, and Cdc20. Expressing physically-
linked Mad2 and Mad3 induces a metaphase arrest that does not require functional kinetochores 
or other checkpoint proteins, indicating the Mad2-Mad3 fusion alone is sufficient to inhibit APC 
activity. We also show that tethering Mad2 directly to Cdc20 can lead to similar arrest that does 
not require Mad3 or other checkpoint components, supporting the idea that the Mad2-Mad3 
fusion induces metaphase arrest by promoting an intimate association between Mad2 and Cdc20. 
Our results suggest that the most downstream event in spindle checkpoint activation is the 
cooperative binding of Mad2 and Mad3 to Cdc20.  
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Results 
Expressing Physically-linked Mad2 and Mad3 Leads to Metaphase Arrest  
 Previous studies in budding yeast showed that both Mad2 and Mad3 are part of the MCC 
and associate with Cdc20 [12, 13, 15]. If Mad2 and Mad3 can both bind to Cdc20, checkpoint 
activation could strengthen the interaction between Mad2 and Mad3, making them bind more 
avidly to Cdc20 and arresting cells in mitosis. In this scenario, an engineered Mad2-Mad3 
complex would artificially activate the spindle checkpoint. To test this idea, we asked if 
overexpressing different versions of Mad2 and Mad3 from the GAL1 promoter could arrest wild-
type yeast cells going through a synchronous cell cycle. We integrated the constructs for 
overexpression into the yeast genome without modifying the endogenous spindle checkpoint 
genes. The GAL1 promoter is transcribed in the presence of galactose and inhibited by glucose. 
We arrested the cells in G1 with !-factor, then released them into media with either glucose or 
galactose, and looked at them three hours later. Cells that are cycling normally have no buds or 
buds that are clearly smaller than the mother cell, whereas cells that have trouble progressing 
through mitosis are enlarged and have distinctive large buds that approach the size of the mother 
cell. Overexpressing Mad2, Mad3, or both Mad2 and Mad3 together had little effect on the cells; 
more than 90% of the population continued to cycle when grown in galactose-containing 
medium (Figure 4-2A). In contrast, overexpressing a Mad2-Mad3 protein fusion, with the C 
terminus of Mad2 fused to the N terminus of Mad3 by an 8-amino acid linker, led to 
accumulation of large budded cells, a hallmark of metaphase arrest (Figure 4-2A). Expressing a 
fusion with Mad3 at the N terminus (Mad3-Mad2) produced similar result (data not shown). 
Cells arrested rapidly, as large budded cells started to accumulate at the first mitosis after 
inducing the Mad2-Mad3 fusion protein (Figure 4-2B). Overexpression of a Mad2-Mad3 fusion  
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Figure 4-2. Overexpressing a Mad2-Mad3 protein fusion leads to metaphase arrest. (A) Cells with the 
indicated PGAL1-driven genes were grown to mid-log phase, arrested in G1 with !-factor, and were released 
into media with either glucose or galactose. After 3 hours of growth, the percentage of large budded cells 
was determined by light microscopy as a measure of metaphase arrest. Error bars represent the standard 
deviation of three independent trials. Two hundred cells were counted for each trial. (B) PGAL1-MAD2-
MAD3 cells were released from G1 arrest into glucose- or galactose-containing media. Samples were 
collected at the indicated time point and the percentage of large budded cells was determined by light 
microscopy. Error bars represent the standard deviation of three independent trials. Two hundred cells 
were counted at each time point for each trial. (C) Cell cycle progression of PGAL1-MAD2-MAD3 cells was 
monitored by Western blots (n=3), which detect securin (Pds1), a protein that is destroyed as cells enter 
anaphase. Cells were grown to mid-log phase and arrested in G1 with !-factor, and were released into 
media with either glucose (top) or galactose (bottom). Western blots against Myc (to visualize Myc-
tagged securin) or actin (loading control) were performed. When the cells were grown in glucose, securin 
level first increased and then dropped rapidly as cells progressed into anaphase. When the Mad2-Mad3 
fusion was overexpressed in the presence of galactose, securin was stabilized, indicating that the cells 
were arrested in metaphase.  
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is therefore able to induce a strong metaphase arrest that does not occur when Mad2 and Mad3 
are overexpressed as two independent proteins in the same cell. 
We confirmed that expressing Mad2-Mad3 fusions prevents APC activation by using a 
biochemical marker for the exit into anaphase. The disappearance of securin (named Pds1 in 
budding yeast), a target of APCCdc20, triggers the metaphase-to-anaphase transition and we 
followed the level of this protein by monitoring the level of epitope-tagged securin (Pds1-
18xMyc) on Western Blots. When the Mad2-Mad3 fusion was not expressed (glucose), securin 
levels rose and fell after cells were released from G1 arrest, indicating normal cell cycle 
progression (Figure 4-2C, top). Overexpressing the Mad2-Mad3 fusion (galactose) stabilized 
securin (Figure 4-2C, bottom).  
 We concluded that overexpressing the Mad2-Mad3 fusion inhibits APC and arrests cells 
in metaphase. To avoid the possibility that this arrest reflects some peculiarity of how Mad2 and 
Mad3 were fused together, we tested the effect of linking Mad2 and Mad3 using a different, non-
covalent method. We fused Mad2 and Mad3 to engineered leucine zipper sequences (EEzip and 
RRzip) that allow the formation of stable heterodimers between two zippers bearing opposing 
charges [16]. When we expressed Mad2-Mad3 heterodimers (by releasing strains containing both 
PGAL1-MAD2-EEzip and PGAL1-MAD3-RRzip into galactose-containing medium), 90% of the cells 
arrested in metaphase (Figure 4-3). The phenotype is not observed when Mad2-EEzip was 
expressed with untagged Mad3 and vice versa, indicating that the arrest depends on interaction 
between Mad2 and Mad3 through the leucine zipper (Figure 4-3). The results confirm that 
overexpressing Mad2 and Mad3 can only induce metaphase arrest if the two proteins are held in 
close proximity. 
  
 ! 80 
 
 
 
 
 
 
 
 
 
Figure 4-3. Overexpressing Mad2 and Mad3 linked by leucine zippers also induces metaphase arrest. 
Cells with the indicated PGAL1-driven genes were released from G1 arrest into glucose- or galactose-
containing media. The percentage of large budded cells was determined by light microscopy after 3 hours 
of growth. Error bars represent the standard deviation of three independent trials. Two hundred cells were 
counted for each trial. 
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Mad2-Mad3 Fusion Does Not Affect Mitotic Spindle Structure 
 The Mad2-Mad3 fusion could lead to metaphase arrest in two ways: directly, by 
inhibiting APCCdc20 activity, or indirectly, by detaching microtubules from kinetochores, thus 
activating the spindle checkpoint. To determine the mode of checkpoint activation, we looked at 
chromosome bi-orientation in cells arrested in metaphase. A chromosome is said to bi-orient 
when the two sister kinetochores attach to microtubules from opposite spindle poles. The sister 
kinetochores can be pulled apart from each other by the spindle, and the separation, which can 
extend to about 0.5 µm, can be visualized by expressing a GFP-Lac repressor fusion protein 
(GFP-LacI) and placing a lactose operator (LacO) array near the centromere [17-20]. Since bi-
orientation is generated when chromosomes align correctly on the spindle, fewer chromosomes 
will bi-orient in cells arrested by Mad2-Mad3 overexpression if the fusion disrupts kinetochore-
microtubule attachments or causes both sister kinetochores to attach to the same spindle pole. 
We integrated PGAL1-MAD2-MAD3 into a strain that expresses GFP-LacI, has a LacO array near 
the centromere of chromosome XV, and CDC20 under the methionine-repressible MET3 
promoter (PMET3-CDC20). When the cells were grown in medium with glucose and methionine, 
Cdc20 was not expressed and the cells arrested in metaphase because they cannot activate the 
APC. Cdc20 depletion leads to metaphase arrest without disrupting the mitotic spindle, and 
around 70% of the cells arrested by this mechanism contained two GFP dots, indicating that 
chromosome XV bi-oriented (Figure 4-4). In about 30% of the cells, the separation between the 
two sister kinetochores is too small to allow the two LacO arrays to be resolved into two dots 
(Figure 4-4). The percentage of cells with two GFP dots was statistically indistinguishable when 
cells were arrested by overexpression of the Mad2-Mad3 fusion (by growing in medium with 
galactose and no methionine) (Figure 4-4). The results show that chromosomes bi-orient  
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Figure 4-4. Metaphase arrest by the Mad2-Mad3 fusion is independent of kinetochore-microtubule 
attachments. Chromosomes bi-orient in cells overexpressing the Mad2-Mad3 fusion. To achieve 
metaphase arrest, cells carrying PGAL1-MAD2-MAD3, GFP-LacI, a LacO array located near the centromere 
of chromosome XV, and PMET3-CDC20 were released from G1 arrest into either medium with glucose and 
methionine (Cdc20 depletion) or medium with galactose and no methionine (Mad2-Mad3 
overexpression). Differential interference contrast (DIC) and GFP images of the cells were taken 3 hours 
after their release from G1. One or two GFP dots can be seen in cells arrested in metaphase. Cells have 
two GFP dots when chromosome XV bi-orients and the two sister kinetochores are separated by the 
spindle. Cells have one GFP dot when chromosome XV mono-orients (sister kinetochores attaching to the 
same spindle pole) or bi-orients but the two sister kinetochores are not pulled apart enough to allow 
resolution of two separate dots. Representative images of metaphase-arrested cells with one or two GFP 
dots are shown (Scale bar, 5 µm). Bar graph shows the percentage of cells with one or two GFP dots 
when they were arrested by Cdc20 depletion or overexpression of the Mad2-Mad3 fusion. Error bars 
represent the standard deviation of three independent trials. Two hundred cells were counted for each 
trial. Around 70% of cells arrested by Cdc20 depletion had two GFP dots. The percentage of cells that 
showed two GFP dots when the cells were arrested by the Mad2-Mad3 fusion is statistically 
indistinguishable (P=0.415; two-tailed Student’s t test). Cells therefore show normal chromosome bi-
orientation when they are arrested in metaphase by the Mad2-Mad3 fusion, suggesting that the fusion 
does not disrupt kinetochore-microtubule connections.  
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normally during arrest induced by the Mad2-Mad3 fusion, suggesting that the fusion leads to 
metaphase arrest directly and does not disrupt normal spindle structure. 
 We next asked if the Mad2-Mad3 fusion could arrest cells that lacked kinetochores. The 
ability of microtubule poisons to activate the spindle checkpoint depends on the presence of 
functional kinetochores [21, 22]. Thus, demonstrating kinetochore-independent arrest would 
strengthen the conclusion that the Mad2-Mad3 fusion does not activate the checkpoint by 
disrupting kinetochore-microtubule connections. We looked at the phenotype of Mad2-Mad3 
overexpression in the absence of functional kinetochores by using an ndc10-1 strain. Ndc10 is a 
member of the CBF3 complex of the budding yeast kinetochore, which recognizes the 
centromeric DNA sequence and acts as the primary link between the chromosome and 
microtubule binding complexes of the kinetochore [23]. At the restrictive temperature (37oC), 
ndc10-1 cells lack functional kinetochores and are therefore unable to activate the spindle 
checkpoint even in the presence of the microtubule deploymerizing drugs benomyl and 
nocodazole [21, 22]. If the Mad2-Mad3 fusion activates the checkpoint by disrupting 
microtubule attachment to the kinetochores, we should not observe metaphase arrest when the 
fusion is overexpressed in ndc10-1 cells at 37oC. To test this prediction, we released ndc10-1 
cells carrying PGAL1-MAD2-MAD3 from a G1 arrest at 25oC or 37oC and monitored the level of 
securin. In cells that were released into glucose-containing medium (to inhibit expression of 
Mad2-Mad3) with benomyl and nocodazole (to depolymerize microtubules) at 37oC, securin 
levels rose and fell, showing that these cells failed to activate the spindle checkpoint (Figure 4-
5) and confirming previous reports that kinetochores are required for normal checkpoint 
activation [21, 22]. In contrast, when these cells overexpressed the Mad2-Mad3 fusion because 
we released them into galactose-containing medium at 37oC, securin was stabilized (Figure 4-5).  
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Figure 4-5. Metaphase arrest by the Mad2-Mad3 fusions does not require functional kinetochores. Cell 
cycle progression of cells with PGAL1-MAD2-MAD3 and ndc10-1 (a mutation that inactivates kinetochore 
at 37˚C) was measured by Western blots (n=3). Cells were released from G1 arrest into media with either 
glucose with benomyl and nocodazole (top) or galactose (bottom) at 25oC or 37oC. Western blots against 
Myc (to visualize Myc-tagged securin) or actin (loading control) were performed. Securin was stabilized 
in galactose-containing medium even at 37oC, indicating that the metaphase arrest is independent of 
functional kinetochores.  
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These results show that the Mad2-Mad3 fusion can arrest cells in metaphase even in the absence 
of functional kinetochores, supporting the idea that the fusion protein is acting downstream of 
the events at the kinetochores and directly inducing metaphase arrest without disrupting 
microtubule attachments to chromosomes.  
 
Metaphase Arrest by Mad2-Mad3 Fusions Does Not Require Other Checkpoint Proteins 
 The Mad2-Mad3 fusion arrests cells in metaphase even when kinetochores are not 
assembled, showing that it bypasses at least one step of the normal spindle checkpoint and 
prompting us to ask whether other checkpoint components are similarly dispensable. We 
integrated the PGAL1-MAD2-MAD3 construct into yeast strains with different spindle checkpoint 
genes deleted (mad1!, mad2!, mad3!, bub1!, and bub3!) and tested the effect of expressing 
Mad2-Mad3 by releasing the cells from G1 arrest into galactose-containing medium. In all cases, 
more than 70% of the population accumulated as large budded cells, indicating that the ability of 
the Mad2-Mad3 fusion to induce metaphase arrest does not require the presence of these 
checkpoint proteins (Figure 4-6). We noticed that bub1! and bub3! strains had a slightly lower 
percentage of large budded cells after 3 hours. The most likely explanation is that bub1! and 
bub3! cells grow more slowly and have a higher rate of death than wild type cells because of 
aneuploidy due to their high chromosome loss rate [24, 25].  
 Next we tested the requirement for two components of the spindle checkpoint, Mps1 and 
Ipl1, that have other essential functions. Mps1 is a kinase that is required for the spindle 
checkpoint, duplication of the spindle pole bodies (SPBs), and mitotic spindle assembly and 
function [26, 27]. Ipl1/Aurora B is another protein kinase, which is required to activate the 
spindle checkpoint in the absence of mechanical tension at the kinetochores [5, 28]; it is also 
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Figure 4-6. Metaphase arrest by Mad2-Mad3 fusions does not require other checkpoint components. 
Cells with PGAL1-MAD2-MAD3 and deletion of the indicated checkpoint genes were released from G1 
arrest into glucose- or galactose-containing media. The percentage of large budded cells was determined 
by light microscopy after 3 hours of growth. Error bars represent the standard deviation of three 
independent trials. Two hundred cells were counted for each trial. Asterisks indicate significant difference 
from wild-type control (*P < 0.05; two-tailed Student’s t test).  
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important for other processes such as spindle disassembly [29]. Since both Mps1 and Ipl1 are 
essential for cell viability, we used conditional alleles to inhibit their activities to ask whether 
they are required for the Mad2-Mad3 fusion to arrest cells. For Mps1, we used the analog-
sensitive allele mps1-as1 [27], which contains an enlarged ATP-binding pocket that makes this 
engineered kinase uniquely sensitive to a bulky protein kinase inhibitor [30]. In the absence of 
the inhibitor, such engineered kinases are functional, and in its presence, they are the only 
protein kinase whose activity is inhibited. We released mps1-as1 cells carrying PGAL1-MAD2-
MAD3 from G1 arrest into media with or without the inhibitor (1NM-PP1, 1-(1, 1-
dimethylethyl)-3-(1-naphthalenylmethyl)-1H-pyrazolo[3, 4-d]pyrimidin-4-amine) and monitored 
securin levels. Cells treated with the inhibitor that were grown in glucose-containing medium (to 
inhibit expression of Mad2-Mad3) with benomyl and nocodazole (to depolymerize microtubules) 
showed the normal rise and fall in securin (Figure 4-7A). This result confirmed that Mps1-as1 
cannot function in the presence of the inhibitor and that cells normally cannot activate the 
spindle checkpoint in the absence of Mps1 activity. On the other hand, cells that were grown in 
galactose-containing medium (to express Mad2-Mad3) stabilized securin even in the presence of 
inhibitor (Figure 4-7A), indicating strong inhibition of APC activity by the Mad2-Mad3 fusion, 
despite the inactivation of Mps1. We performed similar experiments to test the requirement for 
Ipl1 by using the analog-sensitive allele, ipl1-as5 [28]. We released ipl1-as5 cells carrying PGAL1-
MAD2-MAD3 from G1 arrest into media with or without a slightly different inhibitor (1NA-PP1, 
1-(1,1-dimethylethyl)-3-(1-naphthalenyl)-1H-pyrazolo[3, 4-d]pyrimidin-4-amine). 
Overexpressing the Mad2-Mad3 fusion stabilized securin even when Ipl1 was inactivated by 
adding the inhibitor (Figure 4-7B). We confirmed that Ipl1 activity in the strain is indeed 
sensitive to the inhibitor as they did not proliferate in the presence of 1NA-PP1 (data not shown).  
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Figure 4-7. Metaphase arrest by Mad2-Mad3 fusions does not require the checkpoint proteins Mps1 and 
Ipl1. (A) Cell cycle progression of cells with PGAL1-MAD2-MAD3 and mps1-as1 was monitored by 
Western blotting (n=3). Cells were released from G1 arrest into media with either glucose with benomyl 
and nocodazole (top) or galactose (bottom), in the absence (-Inhibitor) or presence (+Inhibitor) of 1NM-
PP1, an inhibitor of the analog-sensitive Mps1. Western blots against Myc or actin (loading control) were 
performed. Both securin and Mps1-as1 are tagged with Myc in the strain, but only the bands 
corresponding to Myc-tagged securin are shown in the figure. Securin was stabilized in galactose-
containing medium even in the presence of inhibitor, indicating that Mps1 activity is not needed for the 
metaphase arrest. (B) The cell cycle progression of cells with PGAL1-MAD2-MAD3 and ipl1-as5 was 
measured by Western blots (n=3). Cells were released from G1 arrest into media with either glucose (top) 
or galactose (bottom), in the absence (-Inhibitor) or presence (+Inhibitor) of 1NA-PP1, an inhibitor of the 
analog-sensitive Ipl1. Western blots against Myc (to visualize Myc-tagged securin) or actin (loading 
control) were performed. Securin was stabilized in galactose-containing medium in the presence of 
inhibitor, showing that Ipl1 activity is not needed for the metaphase arrest. The cause of the delay in 
accumulation of securin in cells grown in medium with galactose and the inhibitor is not known.  
 ! 89 
Our results thus show that both Mps1 and Ipl1 activity are dispensable for metaphase arrest by 
the Mad2-Mad3 fusion. 
 
Directly Tethering Mad2 to Cdc20 Induces Metaphase Arrest  
 Why does fusing Mad2 to Mad3 activate the checkpoint when the overexpression of the 
two separate proteins does not? One possibility is that each protein binds independently but 
weakly to Cdc20, whereas activation of the checkpoint requires stable binding of Mad2 or Mad3 
to the Cdc20. In this scenario, the Mad2-Mad3 fusion would bind Cdc20 strongly since it would 
have a higher avidity for Cdc20 compared to Mad2 or Mad3 alone. Both the Mad2 and Mad3 
region of the fusion protein can bind Cdc20, and either the Mad2-Cdc20 or Mad3-Cdc20 
interactions would prevent the Mad2-Mad3 fusion from completely dissociating from Cdc20. 
Thus the fusion protein would bind Cdc20 tightly and inhibit APCCdc20 activity even in the 
absence of other checkpoint components. This model also explains how Mad2 and Mad3 could 
associate with Cdc20 in budding yeast throughout the cell cycle [12, 15] without activating the 
checkpoint until some signals from the checkpoint increased the strengths of the interactions 
between Mad2, Mad3, and Cdc20. 
 If the stable binding of Mad2-Mad3 to Cdc20 causes metaphase arrest, we should be able 
to induce a similar phenotype by artificially tethering Mad2 or Mad3 to Cdc20 to form a tight 
complex. To test this hypothesis, we investigated the effect of heterodimerizing Mad2 or Mad3 
with Cdc20 using the engineered leucine zipper system [16]. We fused the endogenous CDC20 
to a negatively charged leucine zipper (making PCDC20-EEzip-CDC20 as the only copy of CDC20 
in the cell) and integrated a construct with either MAD2 or MAD3 fused to a positively charged 
leucine zipper (RRzip) under the GAL1 promoter (while leaving the endogenous MAD2 and 
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MAD3 loci intact). We released the cells from G1 arrest into galactose-containing medium to 
overexpress the checkpoint fusion constructs, which would then be tethered to EEzip-Cdc20. In 
cells with PCDC20-EEzip-CDC20 and PGAL1-MAD3-RRzip, the majority of the population 
continued to cycle when they were grown in medium with galactose, showing that binding of 
Mad3 to Cdc20 alone was unable to stop the cell cycle (Figure 4-8A). In contrast, around 90% 
of cells expressing both PCDC20-EEzip-CDC20 and PGAL1-MAD2-RRzip arrested in mitosis 
(Figure 4-8A). The result shows that simply tethering Mad2 to Cdc20 leads to strong metaphase 
arrest. To confirm that the arrest is due to binding of Mad2 to Cdc20 via the leucine zippers, we 
performed the same experiment with a strain that expresses untagged Cdc20 in addition to 
EEzip-Cdc20 and Mad2-RRzip. In this case, the cells continued to cycle even in galactose-
containing medium (Figure 4-8A), showing that the metaphase arrest is due to direct binding of 
Mad2 to Cdc20 and can be overcome by Cdc20 that is not tethered to Mad2. The normal cell 
cycle observed in cells with free (untagged) Cdc20 also suggests that tethering Mad2 to Cdc20 
does not have any obvious detrimental effects besides inhibition of APC activity. 
 We then asked what would happen if Mad2-RRzip is expressed from the MAD2 promoter 
instead of being overexpressed. Since the level of Mad2 in budding yeast exceeds that of Cdc20 
[31], all Cdc20 should be tethered by Mad2 when both EEzip-Cdc20 and Mad2-RRzip are 
expressed from their endogenous promoters. We mated haploid cells carrying both PCDC20-
EEzip-CDC20 and PCDC20-CDC20 (at the URA3 locus) with cells carrying PMAD2-MAD2-RRzip. 
We then sporulated the diploids and dissected the tetrads to look at viability of the spores. Cells 
expressing both EEzip-Cdc20 and Mad2-RRzip failed to form visible colonies or only formed 
very small colonies (Figure 4-8B and Table 4-1). When the small colonies were examined 
microscopically, they were mostly made up of mitotically arrested cells (data not shown),  
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Figure 4-8. Tethering Mad2 directly to Cdc20 leads to metaphase arrest. (A) Cells with PCDC20-EEzip-
CDC20 and the indicated PGAL1-driven genes were released from G1 arrest into glucose- or galactose-
containing media. The percentage of large budded cells was determined by light microscopy after 3 hours 
of growth. Error bars represent the standard deviation of three independent trials. Two hundred cells were 
counted for each trial. Cells in the last column contain PCDC20-EEzip-CDC20, PGAL1-MAD2-RRzip, and an 
untagged copy of Cdc20 ( PCDC20-CDC20) and thus cannot be arrested in mitosis by expressing Mad2-
RRzip. (B) Cells expressing EEzip-Cdc20 and Mad2-RRzip from the endogenous CDC20 and MAD2 
promoters display growth defects that can be overcome by expressing untagged Cdc20. Diploids that are 
heterozygous for three manipulated genes, PCDC20-EEzip-CDC20, PMAD2-MAD2-RRzip, and PCDC20-
CDC20@URA3, were sporulated and a total of 15 tetrads were dissected (also see Table 4-1). 
Representative image of a tetrad on rich, glucose-containing plate after 2 days of growth at 30oC is 
shown. The “+” signs indicate proteins that are expressed based on the genotypes of each spore, which 
were determined by replica plating the tetrad onto dropout or drug plates. The genotype of spore c, which 
failed to form visible colonies, was inferred from the genotypes of other spores from the same tetrad.
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 Colony size 
Genotype Very Small/No colony Regular 
 PCDC20-EEzip-CDC20  PMAD2-MAD2-RRzip 7 0 
 PCDC20-EEzip-CDC20  PMAD2-MAD2-RRzip  PCDC20-
CDC20@URA3 
0 12 
Number of tetrads dissected : 15   
 
 
Table 4-1. Colony size of spores with indicated genotypes from tetrad dissection (also see Figure 4-8B).   
The genotypes of the spores that failed to form colonies or formed very small colonies were inferred from 
the genotypes of the other spores assuming that all three heterozygously modified genes (PCDC20-EEzip-
CDC20 , PMAD2-MAD2-RRzip, and PCDC20-CDC20@URA3) showed Mendelian (2:2) segregation. 
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suggesting that the cells had trouble progressing through mitosis. On the other hand, cells that 
expressed untagged Cdc20 in addition to EEzip-Cdc20 and Mad2-RRzip showed normal growth 
(Figure 4-8B and Table 4-1). Our results show that the metaphase arrest seen in our earlier 
experiments is not simply due to a high, non-physiological level of the fusion proteins, since 
wild type expression of Mad2 is sufficient to arrest cells when Mad2 is constitutively tethered to 
Cdc20.    
 Since Cdc20 is the target of the spindle checkpoint, the stable binding of Mad2 to Cdc20 
should be the last step in spindle checkpoint activation. If the hypothesis is correct, the arrest 
induced by tethering Mad2 to Cdc20 will not require other checkpoint components. To test this 
prediction, we introduced PGAL1-MAD2-RRzip and PCDC20-EEzip-CDC20 into yeast strains with 
different checkpoint genes deleted (mad1!, mad2!, mad3!, bub1!, and bub3!). We looked at 
the effect of tethering Mad2 to Cdc20 by releasing these cells from G1 arrest into galactose-
containing medium. In all five checkpoint mutants, at least 55% of the population accumulated 
as large budded cells, showing that the metaphase arrest does not require the presence of these 
checkpoint proteins (Figure 4-9). We noted that the percentages of metaphase-arrested cells 
were significantly lower in mad3!, bub1!, and bub3! strains. The smaller number of large 
budded cells in bub1! and bub3! strains is again probably due to the growth defects exhibited by 
these strains. The weaker phenotype in mad3! cells, on the other hand, may suggest a role of 
Mad3 in strengthening the inhibition of Cdc20 by Mad2. The metaphase arrest also does not 
require Mps1, Ipl1, or functional kinetochores (Figure 4-10), further suggesting that tethering 
Mad2 to Cdc20 recapitulates a downstream event in checkpoint activation and leads to direct 
inhibition of APC. 
  
   
! 94 
 
 
 
 
 
 
Figure 4-9. The metaphase arrest produced by tethering Mad2 to Cdc20 does not require other checkpoint 
components. Cells with PCDC20-EEzip-CDC20, PGAL1-MAD2-RRzip, and deletion of the indicated 
checkpoint genes were released from G1 arrest into glucose- or galactose-containing media. The 
percentage of large budded cells was determined by light microscopy after 3 hours of growth. Error bars 
represent the standard deviation of three independent trials. Two hundred cells were counted for each 
trial. Asterisks indicate significant difference from wild-type control (*P < 0.05 and **P < 0.01; two-
tailed Student’s t test). 
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Figure 4-10. Metaphase arrest induced by tethering Mad2 to Cdc20 does not require Mps1, Ipl1, or 
functional kinetochores. (A) Cell cycle progression of cells with PCDC20-EEzip-CDC20, PGAL1-MAD2-
RRzip and mps1-as1 was monitored by Western blots (n=3). Cells were released from G1 arrest into media 
with either glucose with benomyl and nocodazole (top) or galactose (bottom), in the absence (-Inhibitor) 
or presence (+Inhibitor) of 1NM-PP1, an inhibitor of the analog-sensitive Mps1. Western blots against 
Myc or actin (loading control) were performed.Securin was stabilized in galactose-containing medium in 
the presence of inhibitor, indicating that Mps1 activity is not required for the metaphase arrest. The cause 
of the delay in accumulation of securin in cells grown in medium with galactose and the inhibitor is not 
known. (B) The cell cycle progression of cells with PCDC20-EEzip-CDC20, PGAL1-MAD2-RRzip and ipl1-
as5 was measured by Western blots (n=3). Cells were released from G1 arrest into media with either 
glucose (top) or galactose (bottom), in the absence (-Inhibitor) or presence (+Inhibitor) of 1NA-PP1, an 
inhibitor of the analog-sensitive Ipl1. Western blots against Myc (to visualize Myc-tagged securin) or 
actin (loading control) were performed. Securin was stabilized in galactose-containing medium even in 
the presence of inhibitor, showing that Ipl1 activity is not needed for the metaphase arrest. The cause of 
the delay in accumulation of securin in cells grown in medium with galactose and the inhibitor is not 
known. (C) Cell cycle progression of cells with PCDC20-EEzip-CDC20, PGAL1-MAD2-RRzip and ndc10-1 
was monitored by Western blots (n=3). Cells were released from G1 arrest into media with either glucose 
with benomyl and nocodazole (top) or galactose (bottom) at 25oC or 37oC. Western blots against Myc (to 
visualize Myc-tagged securin) or actin (loading control) were performed. Securin was stabilized in 
galactose-containing medium at 37oC, showing that the metaphase arrest is independent of functional 
kinetochores. 
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Figure 4-10 (Continued).
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The Phenotypes of Tethering Mad2 Mutants to Cdc20 Support the Mad2-template Model  
 The phenotypes we produced by tethering Mad2 to Cdc20 can be rationalized by the 
Mad2-template model. This model is based on the structures of different conformations of Mad2 
[32-35], structural analysis of the Mad1-Mad2 complex [34], and imaging the dynamics of 
checkpoint proteins at the kinetochore [36-40]. In the model, Mad1 dimers associate with 
unattached kinetochores and bind Mad2 (Figure 4-11). This leads to the formation of Mad1-
Mad2 complexes with Mad2 in the “closed” conformation (C-Mad2), which wraps around Mad1 
or Cdc20. The complex in turn recruits a different conformer of Mad2, “open” Mad2 (O-Mad2), 
and facilitates its association with Cdc20 and conversion into closed Mad2. Mad2 can associate 
with Cdc20 throughout the budding yeast cell cycle [15], but this is insufficient to activate the 
checkpoint, likely because the interaction is too short-lived to allow the conformational change 
that is required to generate the closed Mad2-Cdc20 complex from open Mad2. The Mad1-Mad2 
complex is therefore required to increase the rate of Mad2 conversion and produce the closed 
Mad2-Cdc20 complex [41]. The model predicts that if Mad2 can stably associate with Cdc20, it 
can eventually reach the closed conformation and inhibit APCCdc20 even in the absence of 
attachment errors or other checkpoint proteins. Our observation that tethering Mad2 to Cdc20 
can directly induce metaphase arrest is consistent with the model.  
 To further test the Mad2-template model, we tethered two previously studied Mad2 
mutants to Cdc20. One mutant is Mad2 lacking its C-terminal 10 amino acid residues and was 
first characterized in HeLa cells [39]. Without this region, Mad2 is unable to close. The Mad2 
mutant cannot activate the checkpoint as it fails to form a stable complex with Mad1 or to bind to 
and inhibit Cdc20 (Figure 4-12A). The corresponding Mad2 mutant in budding yeast (MAD2!C) 
also has no checkpoint function [42]. We integrated PGAL1-MAD2!C-RRzip into cells expressing 
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Figure 4-11. The Mad2-template model. Mad1 dimers associate with unattached kinetochores and bind 
Mad2, converting them from “open” (O-Mad2) to “closed” (C-Mad2) conformation. The Mad1-Mad2 
complexes at the kinetochores (the “templates”) then recruit additional open Mad2, allowing the 
formation of closed Mad2-Cdc20 complexes.  
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Figure 4-12. Metaphase arrest induced by tethering Mad2 mutants to Cdc20 supports the Mad2-template 
model. (A) The behavior of Mad2 mutants in the context of the Mad2-template model. (Top) Mad2!C 
lacks the C-terminal amino acid residues and cannot convert to the closed Mad2 conformation. It fails to 
activate the spindle checkpoint since it is unable to form a stable complex with Mad1 and to bind to and 
inhibit Cdc20. (Bottom) The double point mutant Mad2RQEA carries the mutations Arg126-Glu and 
Gln127-Ala. The changes inhibit the binding between free Mad2 and closed conformation of Mad2 found 
in the Mad1-Mad2 complex, which inactivates the spindle checkpoint by preventing the formation of C-
Mad2-Cdc20 complexes. The mutations also affect the interaction of Mad2 with BUBR1 (mammalian 
version of Mad3) and the formation of stable MCC. (B) Effects of tethering Mad2 mutants to Cdc20. 
Cells with PCDC20-EEzip-CDC20 and the indicated PGAL1-driven genes were released from G1 arrest into 
glucose- or galactose-containing media. The percentage of large budded cells was determined by light 
microscopy after 3 hours of growth. Error bars represent the standard deviation of three independent 
trials. Two hundred cells were counted for each trial. Tethering the Mad2 mutant that can reach the closed 
conformation, but cannot induced conformational conversion in other Mad2 molecules (Mad2RQEA), does 
activate the checkpoint, but tethering the mutant that cannot achieve the closed conformation (Mad2!C) 
does not. 
  
 ! 100 
EEzip-Cdc20. When the cells were grown in galactose-containing medium, the majority of the 
population continued to cycle (Figure 4-12B). Thus tethering Mad2!C to Cdc20 is unable to 
induce metaphase arrest, which supports the notion that only closed Mad2 can inhibit Cdc20.  
 Next we tested the Mad2 double point mutant Arg126-Glu/Gln127-Ala (Mad2RQEA). 
These two mutated residues have been conserved in eukaryotic evolution and are essential for the 
binding of soluble Mad2 to the closed conformation of Mad2 found in the Mad1-Mad2 complex 
[39, 42] (Figure 4-12A). Since this interaction is important for facilitating the formation of 
closed Mad2-Cdc20 complex, this Mad2 mutant does not have normal checkpoint function in 
either budding yeast [42] or HeLa cells [39]. These residues have also been shown to be 
important for the binding of Mad2 to BUBR1, the mammalian equivalent of Mad3, and the 
formation of MCC in vitro [43]. To test the effect of tethering Mad2RQEA to Cdc20, we integrated 
PGAL1-MAD2RQEA-RRzip into cells expressing EEzip-Cdc20. When the cells were released into 
galactose-containing medium, 95% of them accumulated at the large-budded state (Figure 4-
12B). The result suggests that when Mad2 is directly tethered to Cdc20, the interaction between 
closed and open Mad2 is dispensable since Mad2 can eventually close and inhibit Cdc20, which 
is again consistent with the Mad2-template model. Since human Mad2RQEA fails to bind to 
BUBR1, our experiment strengthens the conclusion that the binding between Mad2 and Mad3 
and the formation of stable MCC is not necessary for the metaphase arrest induced by tethering 
Mad2 to Cdc20. 
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Conclusions and Discussion 
 We showed that expressing a Mad2-Mad3 protein fusion arrests budding yeast in 
metaphase. The arrest does not require other checkpoint proteins and is not due to disruption of 
microtubule attachments to kinetochores. We obtained similar results by non-covalently linking 
Mad2 to Mad3 using leucine zippers, indicating that constitutive association between Mad2 and 
Mad3 is sufficient to prevent progression through mitosis. Finally, we showed that directly 
tethering Mad2 to Cdc20 also arrests cells in metaphase and that this arrest is independent of 
other checkpoint proteins. Our results support a model in which Mad2 and Mad3 are the most 
downstream components of the checkpoint pathway and cooperate to bind to Cdc20 and inhibit 
the APC. 
 
Linking Mad2 and Mad3 Arrests Cells in the Absence of Spindle Damage 
 A high level of Mad2 protein arrests cells in metaphase in a variety of organisms 
including Xenopus embryos [44, 45], fission yeast [46], and tissue culture cells [36, 39, 47]. The 
exact mechanism leading to the arrest likely differs between organisms; the arrest only requires 
Mad3 in fission yeast [48] and is independent of Mad1 in Xenopus embryos [44], but it requires 
Mad1 in tissue culture cells [47]. Our experiments show that in budding yeast, a high level of 
Mad2 alone is not enough to induce metaphase arrest, whereas expression of physically-linked 
Mad2 and Mad3 arrests cells independently of other checkpoint components. The results in 
different species may reflect differences in the interactions of Mad2 with other checkpoint 
proteins, the maximum expression of Mad2 that can be obtained, or the relative importance of 
Mad2 in checkpoint activation.  
 ! 102 
 Mps1 overexpression in budding yeast can activate the spindle checkpoint without 
disrupting the mitotic spindle [49]. Unlike the metaphase arrest caused by linking Mad2 to 
Mad3, the effect of Mps1 overexpression depends on other checkpoint proteins; checkpoint 
mutants overexpressing Mps1 progress through mitosis without significant delay. Mps1 therefore 
likely represents an upstream activator that coordinates with other checkpoint proteins to activate 
the spindle checkpoint, while the Mad2-Mad3 fusion acts as a downstream effector that inhibits 
APCCdc20 even in the absence of other checkpoint proteins and functional kinetochores. Unlike 
many other checkpoint complexes previously identified in vivo [11-13], the Mad2-Mad3 fusion 
represents a minimal complex that can induce metaphase arrest independently of other known 
checkpoint components. Because we inactivated the other checkpoint proteins individually to test 
their requirements for arrest by Mad2-Mad3 fusions, we cannot rigorously exclude the 
possibility that two or more of them play a redundant role in helping the fusion to inhibit Cdc20, 
but we believe that Mad2-Mad3 is a direct inhibitor of APCCdc20 and functions downstream of 
events at the kinetochore.  
  
Stable Binding of Mad2 to Cdc20 Can Lead to Metaphase Arrest 
 We believe the Mad2-Mad3 fusion arrests cells because its high avidity for Cdc20 allows 
Mad2 to stay in close proximity to Cdc20 for long enough for Mad2 to adopt the closed 
conformation and inhibit Cdc20. Tethering Mad2 to Cdc20 using leucine zippers arrests cells in 
metaphase, supporting the hypothesis. Expressing both Mad2 and Cdc20 fused to leucine zippers 
from their endogenous promoters is sufficient to induce metaphase arrest in cells, showing that a 
physiological level of Mad2 can inhibit Cdc20 if the two proteins are forced to stably associate 
with each other. The inhibition by Mad2 is likely direct, as all other known checkpoint proteins 
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are dispensable for the arrest. We noticed that the metaphase arrest is weaker, but not absent, in 
mad3! cells. This result suggests that when Mad2 is stably associated with Cdc20, it can directly 
inhibit Cdc20 and recruit Mad3 to further strengthen the inhibition, and that while the 
recruitment of Mad3 potentiates Cdc20 inhibition, it is not essential to inactivate the APC in a 
significant fraction of cells. Consistent with this claim, most known checkpoint proteins, 
including Mad2, are necessary for the stable interaction between Cdc20 and Mad3 in budding 
yeast, whereas the binding of Mad2 to Cdc20 only requires Mad1 and Mps1 [12, 13, 15]. Our 
results support the hypothesis that Mad2 and Mad3 cooperate to bind to and inhibit Cdc20, and 
suggest that this event represents the last and essential step in spindle checkpoint activation. We 
believe that Mad3 has an auxiliary role and becomes dispensable when Mad2 can constitutively 
associate with Cdc20.  
 Tethering Mad3 to Cdc20 alone is unable to induce metaphase arrest in cells. We favor 
the interpretation that the main role of Mad3 is to promote the inhibition of Cdc20 by Mad2. In 
contrast, in vitro experiments have shown that BUBR1, the mammalian version of Mad3, could 
inhibit APCCdc20 alone and also act synergistically with Mad2 to repress APC activity [50, 51]. In 
budding yeast, Mad3 can also inhibit APCCdc20 in vitro in the absence of added Mad2 [Schuyler 
S, personal communication]. Several factors could account for the discrepancies between the in 
vitro data and our observations. The in vitro experiments, which contain reticulocyte lysate and 
APC purified from yeast or mammalian cells, may be contaminated by a low level of Mad2 that 
complicated the results. We also cannot exclude the possibility that inhibition of Cdc20 by Mad3 
requires a specific orientation of the two proteins that cannot be achieved when they are tethered 
together by leucine zippers. 
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Implications for the Mad2-template Model  
 The Mad2-template model is a prominent model that explains how the checkpoint 
proteins respond to events at the kinetochore and activate the spindle checkpoint. The model 
predicts that the requirements for kinetochores and other checkpoint proteins can be bypassed if 
Mad2 can stably associate with Cdc20, which is consistent with our result that tethering Mad2 to 
Cdc20 can directly induce metaphase arrest. The phenotypes observed when we tethered two 
known Mad2 mutants (Mad2!C and Mad2RQEA) to Cdc20 further support the Mad2-template 
model and strengthen our claim that the binding of Mad2 to Cdc20 is the most downstream event 
in checkpoint activation.  
 One extension from the Mad2-template model is that the closed Mad2-Cdc20 complex 
can recruit open Mad2 and trigger the production of additional closed Mad2-Cdc20, thereby 
amplifying the checkpoint signal [6]. When we tethered Mad2 to Cdc20 in cells that also express 
untagged Cdc20 (which cannot be tethered), the cells failed to arrest in metaphase, indicating 
that the Mad2-Cdc20 complex is unable to inhibit the untagged Cdc20. Amplification from 
closed Mad2-Cdc20 complexes is therefore unlikely to be a factor in further amplifying the 
checkpoint signal, and alternative mechanisms are required to ensure complete inhibition of 
APCCdc20 during normal checkpoint activation. Our results in cells with untagged Cdc20 also 
argue that tethering Mad2 to Cdc20 leads to direct inhibition of APC and does not have any 
obvious side effects as these cells progressed through the cell cycle normally.  
 Overall our results support the model that Mad2-Mad3 fusions and the association of 
Mad2 with Cdc20 inhibit APC activity by acting downstream of all other known checkpoint 
components. The two systems represent new ways for studying APC inhibition in vivo 
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independently of other checkpoint proteins and upstream kinetochore signals, which may allow 
us to better understand the molecular details of spindle checkpoint activation. 
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Materials and Methods 
Yeast Strains and Methods 
 Strains used in this study are listed in Table 4-2. All strains are derivatives of W303 
(ade2-1  his3-11,15  leu2-3,112  trp1-1  ura3-1  can1-100). Strains were constructed using 
standard genetic techniques. All media were prepared using established recipes [52], and contain 
2% wt/vol of the indicated sugar as the carbon source. To prepare media containing benomyl and 
nocodazole, DMSO stocks of methyl 1-(butylcarbamoyl)-2-benzimidazolecarbamate (benomyl) 
(Sigma-Aldrich, St. Louis, MO) and nocodazole (Sigma-Aldrich, St. Louis MO) were added to 
yeast extract and peptone (YEP) with 2% wt/vol glucose to a final concentration of 30µg/ml of 
each drug. Diploid strains were sporulated in liquid culture by growing to saturation in YEP with 
2% wt/vol glucose, diluting into YEP with 2% wt/vol potassium acetate for 12 hours at 30oC, 
washing with water, and resuspending in 2% potassium acetate at 25oC. 
 
Cell Cycle Analysis by Light Microscopy 
 To look at the effect of overexpressing different checkpoint constructs on cell cycle 
progression, cells were first grown to mid-log phase (107 cells/ml) in YEP with 2% raffinose 
(wt/vol). Cells were then arrested in G1 by adding 10µg/ml !-factor (Bio-Synthesis, Lewisville, 
TX) and incubated for 2 hours at 30oC. Cells were washed four times to remove !-factor and 
resuspended in YEP with either 2% glucose (wt/vol) or 2% galactose (wt/vol). After growing for 
3 hours at 30oC, the cultures were briefly sonicated to separate cells that fail to dissociate 
completely after division and the percentage of large-budded cells in each sample was 
determined by light microscopy. For the time course experiment in Figure 2B, the cultures were 
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handled the same way except samples were taken every 30 min after releasing from G1 arrest and 
counted. 
 
Cell Cycle Analysis by Western Blots 
 To monitor cell cycle progression by Western blots, cells were grown and arrested in G1 
as described above, and released into the indicated media. 1µg/ml !-factor was used for bar1! 
strains. For experiments with ndc10-1 strains, cells were grown to mid-log phase (107 cells/ml) in 
YEP with 2% raffinose (wt/vol) at 25oC. Cells were then arrested in G1 by adding 10µg/ml !-
factor and incubated for 2 hours at 25oC, and shifted to 37oC for 30 min to inactivate ndc10-1. 
Cells were washed four times to remove !-factor and resuspended in the indicated media at 
37oC. 10µg/ml !-factor was added at 60 min after release from G1 arrest in all Western blot 
experiments to prevent cells from progressing into the next S phase. 
 For experiments with mps1-as1 strains, DMSO (-Inhibitor) or 10µM of 1NM-PP1 
(+Inhibitor) was added to the media after releasing the cells from G1 arrest to inhibit the activity 
of  Mps1-as1. For experiments with ipl1-as5 strains, DMSO (-Inhibitor) or 50µM of 1NA-PP1 
(+Inhibitor) was added to inhibit the activity of Ipl1-as5.  
 In all Western blot experiments, 1ml samples of the culture were collected at the 
indicated time points, and the cells were pelleted by centrifugation for 1 min at room 
temperature. The supernatant was removed, and cell pellets were stored at -80oC.  
 Cell pellets were lysed using a NaOH/"-mercaptoethanol-based protocol [53]. Proteins 
samples were loaded onto and separated in 10% Criterion Tris-HCl polyacrylamide gel (Bio-
Rad, Hercules, CA). Proteins were transferred overnight to nitrocellulose (Whatman, Picataway, 
NJ). Western blotting for Myc-tagged securin were performed using anti-Myc 9E10 antibodies 
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(Roche Applied Science, Indianapolis, IN) at a 1:500 dilution, and actin was detected with anti-
actin antibodies (Abcam, Cambridge, MA) used at a 1:2000 dilution. Horseradish peroxidase- 
conjugated goat anti-mouse (Santa Cruz Biotechnology, Santa Cruz, CA) was used as the 
secondary antibody at a 1:2000 dilution. The secondary antibody was detected by SuperSignal 
West Dura Chemiluminescent Substrate (Thermo Fisher Scientific, Rockford, IL) and the blot 
was imaged with an AlphaImager (ProteinSimple, Santa Clara, CA).  
 
Fluorescence Microscopy 
 To look at cells arrested in metaphase by the Mad2-Mad3 fusions using live-cell 
microscopy, cells were synchronized in G1 with 1µg/ml !-factor and then subjected to a constant 
flow of indicated media for 3 hours at room temperature using the ONIX microfluidic perfusion 
platform (CellASIC, Hayward, CA). Fluorescence microscopy was performed using Nikon Ti-E 
inverted microscope (Nikon, Melville, NY) equipped with a 60x objective (PlanApo, numerical 
aperture 1.4, oil), GFP filter (Chroma Technology, Bellow Falls, VT), and a CoolSNAP charge-
coupled device camera (Photometrics, Tucson, AZ). Z-stacks of 25 sections were acquired using 
exposure times of 350 ms in Metamorph (Molecular Devices, Sunnyvale, CA). Z-stacks were 
combined into a single maximum intensity projection with ImageJ (NIH).  
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Table 4-2. Strains used in this Chapter.  
Strain Name Genotype 
DLY605 
DLY614 
DLY663 
DLY664 
DLY665 
DLY685 
DLY733 
DLY752 
DLY885 
DLY944 
DLY945 
DLY946 
DLY953 
DLY954 
DLY955 
DLY990 
DLY992 
DLY996 
DLY997 
DLY1014 
 
DLY1036 
DLY1038 
MATa  PGAL1-MAD2@URA3 
MATa  PGAL1-MAD2-MAD3@URA3 
MATa  PGAL1-MAD2-MAD3@URA3  mad2!::Kanr 
MATa  PGAL1-MAD2-MAD3@URA3  mad3!::Kanr 
MATa  PGAL1-MAD2-MAD3@URA3  bub1!::Kanr 
MATa  PGAL1-MAD2-MAD3@URA3  mad1!::HIS3 
MATa  PGAL1-MAD2@URA3  PGAL1-MAD3@HIS3 
MATa  PGAL1-MAD2-MAD3@URA3  bub3!::Kanr 
MATa  cdc20!::PCDC20-EEzip-CDC20-Kanr  PGAL1-MAD2-RRzip@URA3 
MATa  cdc20!::PCDC20-EEzip-CDC20-Kanr  PGAL1-MAD3-RRzip@URA3 
MATa  cdc20!::PCDC20-EEzip-CDC20-Kanr  PGAL1-MAD2!C-RRzip@URA3 
MATa  cdc20!::PCDC20-EEzip-CDC20-Kanr  PGAL1-MAD2RQEA-RRzip@URA3 
MATa  cdc20!::PCDC20-EEzip-CDC20-Kanr  PGAL1-MAD2-RRzip@URA3  mad1!::HIS3 
MATa  cdc20!::PCDC20-EEzip-CDC20-Kanr  PGAL1-MAD2-RRzip@URA3  mad2!::Kanr 
MATa  cdc20!::PCDC20-EEzip-CDC20-Kanr  PGAL1-MAD2-RRzip@URA3  bub3!::Kanr 
MATa  PGAL1-MAD3@URA3 
MATa  PGAL1-MAD2-MAD3@URA3  PDS1::18"MYC::LEU2 
MATa  cdc20!::PCDC20-EEzip-CDC20-Kanr  PGAL1-MAD2-RRzip@URA3  mad3!::LEU2 
MATa  cdc20!::PCDC20-EEzip-CDC20-Kanr  PGAL1-MAD2-RRzip@URA3  bub1!::HIS3 
MATa  PGAL1-MAD2-MAD3@URA3  mps1!::Kanr::10"MYC-mps1-as1-TRP1  
PDS1::18"MYC::LEU2 
MATa  PGAL1-MAD2-MAD3@URA3  ndc10-1  PDS1::18"MYC::LEU2 
MATa  PGAL1-MAD2-EEzip@HIS3  PGAL1-MAD3-RRzip@URA3 
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Table 4-2 (Continued). Strains used in this Chapter.  
Strain Name Genotype 
DLY1061 
 
DLY1062 
 
DLY1070 
 
DLY1074 
DLY1075 
DLY1076 
DLY1077 
 
DLY1079 
 
DLY1092 
MATa  PGAL1-MAD2-MAD3@URA3  ipl1!::Kanr::ipl1-as5-LEU2  PDS1::18"MYC::LEU2  
bar1! 
MATa  cdc20!::PCDC20-EEzip-CDC20-Kanr  PGAL1-MAD2-RRzip@URA3  
mps1!::Kanr::10"MYC-mps1-as1-TRP1  PDS1::18"MYC::LEU2 
MATa  cdc20!::PCDC20-EEzip-CDC20-Kanr  PGAL1-MAD2-RRzip@URA3  ndc10-1  
PDS1::18"MYC::LEU2 
MATa  PGAL1-MAD2@HIS3  PGAL1-MAD3-RRzip@URA3 
MATa  PGAL1-MAD2-EEzip@HIS3  PGAL1-MAD3@URA3 
MATa  cdc20!::PCDC20-EEzip-CDC20-Kanr  PGAL1-MAD2-RRzip@URA3  PCDC20-CDC20@HIS3 
MATa  cdc20!::PCDC20-EEzip-CDC20-Kanr  PGAL1-MAD2-RRzip@URA3 ipl1!::Kanr::ipl1-as5-
LEU2  PDS1::18"MYC::LEU2 
MATa/#  PCDC20-EEzip-CDC20-Kanr/ CDC20  PMAD2-MAD2-RRzip-His3MX6/MAD2  PCDC20-
CDC20@URA3/ura3-1   
MATa  PGAL1-MAD2-MAD3@ADE2  cdc20!:: PMET3-3"HA-CDC20-TRP1  PCUP1-GFP-
LacI@HIS3  LacO256-URA3@CEN15  PDS1::18"MYC::LEU2  bar1! 
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Chapter Five 
 
Conclusions, Discussion, and Future Directions
 ! 117 
Abstract 
 Here we summarize the findings described in preceding chapters. We also discuss 
unresolved questions, such as the exact molecular details of metaphase arrest induced by 
the Bub1 dimer and the Mad2-Mad3 fusion, and propose experiments to address them in 
the future.     
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Summary of Major Results  
 The spindle checkpoint is essential for accurate chromosome segregation during 
mitosis by inhibiting cell cycle progression until all chromosomes are properly lined up 
on the mitotic spindle. The kinetochore signals to the spindle checkpoint when 
attachment errors arise. The kinetochore may behave like a scaffold and recruit different 
spindle checkpoint components in the absence of proper microtubule attachment, thereby 
facilitating the assembly of diffusible inhibitory complexes and inducing cell cycle arrest 
(reviewed in Chapter One).  
 To determine whether localizing checkpoint proteins constitutes an important step 
in the checkpoint pathway, we created a system in budding yeast for recruiting 
checkpoint components fused to the lactose repressor (LacI) to an array of lactose 
operators (LacO) on the chromosome (Chapter Two). Recruiting the checkpoint protein 
Bub1 and a mutant version of Bub3 (BUB3-A117T) to the chromosome appeared to 
activate the spindle checkpoint. We showed that the metaphase arrest is in fact caused by 
dimerization of Bub1 when it is fused to LacI rather than the recruitment of Bub1 to the 
chromosome (Chapter Three). The cell cycle arrest by the Bub1 dimer depends on the 
presence of other checkpoint proteins but not functional kinetochores. We found that a 
fraction of Bub1 may exist as a dimer during the normal cell cycle, which is consistent 
with the idea that the Bub1 dimer may be an upstream component in the spindle 
checkpoint pathway. 
 The fact that artificially dimerizing Bub1 is sufficient to activate the checkpoint 
led us to test the consequences of fusing checkpoint proteins to each other. We showed 
that fusing Mad2 and Mad3 arrests cells in metaphase independently of other checkpoint 
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proteins (Chapter Four). We believe that combining Mad2 and Mad3 arrests cells because 
the hybrid protein is able to bind tightly to Cdc20, the main target of the spindle 
checkpoint. We further demonstrated that artificially tethering Mad2 directly to Cdc20 
also arrests cells and this arrest does not depend on any other checkpoint components. 
We concluded from our experiments that the stable binding of Mad2 and Mad3 to Cdc20 
is sufficient to inhibit APC activity and represents the most downstream event in spindle 
checkpoint activation.  
 
Discussion and Future Directions 
Localizing Spindle Checkpoint Proteins at the Kinetochore 
 While our results provide some insights into the mechanism of spindle checkpoint 
activation, they raise many more unanswered questions. One of them is whether the 
model we started out to test (the kinetochore scaffold model) accurately describes how 
the spindle checkpoint is activated. Besides discovering the unexpected properties of 
Bub1-LacI, we found that recruiting other checkpoint protein fusions to a LacO array has 
no obvious effect on cell cycle progression. While the results may indicate that simply 
localizing checkpoint components to a DNA region is not sufficient to induce metaphase 
arrest, other factors may contribute to the lack of phenotype. First we cannot exclude the 
possibility that the functions of certain checkpoint proteins are compromised when they 
are fused to LacI. Second, the checkpoint proteins may have to be in specific orientations 
relative to each other when they are recruited to the kinetochore to activate the spindle 
checkpoint, and these orientations cannot be achieved when the same proteins are 
recruited to the LacO DNA via LacI. Third, the kinetochore may play an active role in 
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modifying the checkpoint components to allow checkpoint activation in addition to acting 
as a scaffold that binds checkpoint proteins. Simply recruiting the checkpoint proteins to 
a DNA region in the absence of kinetochore components will thus fail to mimic the actual 
events at the kinetochore. We attempted to address this issue by also expressing a protein 
fusion of the kinetochore protein Ask1 fused to LacI. We have previously shown that 
Ask1-LacI can bind to LacO and recruit other kinetochore components, forming a 
“synthetic kinetochore” at the LacO region that is able to perform many of the natural 
kinetochore functions [1]. Recruiting individual checkpoint proteins (besides Bub1-LacI) 
and a number of combinations of different checkpoint proteins to LacO repeats in the 
presence of the synthetic kinetochore again did not have any obvious effect (data not 
shown). It is possible that the synthetic kinetochore is missing certain kinetochore 
components that are involved in modifying the checkpoint proteins. Alternatively, the 
checkpoint proteins may need to have specific associations with the kinetochore, and 
simply localizing the synthetic kinetochore close to the checkpoint components is not 
sufficient to produce the necessary interactions. 
 One future direction is to determine the effect of localizing checkpoint proteins 
directly to the kinetochore, which is able to induce ectopic checkpoint activation in 
fission yeast [2] and human tissue culture cells [3]. We can either fuse checkpoint 
proteins directly to one of the kinetochore components, or use the engineered leucine 
zippers (EEzip and RRzip) to generate heterodimers between checkpoint proteins and 
components of the kinetochore. One advantage of using the leucine zippers is that we can 
systematically test all the possible pairings between checkpoint proteins and kinetochore 
components and determine whether localizing a particular checkpoint protein to a 
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specific region of the kinetochore complex is able to initiate the spindle checkpoint. The 
results may help us understand how the kinetochore interacts with the spindle checkpoint 
proteins to induce cell cycle arrest. 
 
Roles of the Bub1 Dimer in the Spindle Checkpoint  
Another important question is how expression of the Bub1 dimer activates the 
spindle checkpoint. We hypothesize that dimerization of Bub1 is important for its 
interaction with Mad1. Bub1 may dimerize strongly only at the kinetochore, and the 
dimer in turn binds dimeric Mad1. The interaction may facilitate the localization and 
activation of the Mad1 dimer, ultimately leading to recruitment of Mad2 and formation of 
Mad1-Mad2 complexes. Bub1 associates with Mad1 in budding yeast when the spindle 
checkpoint is activated [4], supporting the idea that the interaction between Mad1 and 
Bub1 is important for the spindle checkpoint, but it is not known if Mad1 can interact 
with the Bub1 dimer. Additional experiments to look at the association between Mad1 
and the Bub1 dimer will hopefully address the role of the Bub1 dimer in the spindle 
checkpoint.  
If the interaction between the Bub1 dimer and Mad1 is important for activating 
the checkpoint, this association must be carefully regulated to prevent ectopic checkpoint 
activation since our results are consistent with the idea that at least a fraction of Bub1 is 
constitutively dimerized. We speculate that overexpression of the artificial Bub1 dimer 
arrests cells in metaphase because a fraction of the dimer escapes the regulation and thus 
activates the checkpoint, for example by stimulating the production of Mad1-Mad2 
complexes. To verify this idea, it will be important to determine how the interaction 
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between Mad1 and the Bub1 dimer is normally controlled. Alternatively, there is no 
negative regulation on the Bub1 dimer and whether the checkpoint stops the cell depends 
on the balance between activation by the Bub1 dimer and inactivation by other 
mechanisms, such as dephosphorylation by protein phosphatase 1 (PP1) [5, 6]. When the 
kinetochores are properly attached, the dimer level is far too low to overcome the 
inactivating mechanisms. A huge increase in the dimer concentration by both 
overexpressing Bub1 and forcing it all to dimerize overwhelms the checkpoint 
inactivating mechanisms and thus arrests cells. It will be helpful to understand the 
localization and dynamics of the Bub1 dimer when it is overexpressed to determine 
whether it behaves differently from the endogenous Bub1 dimer.  
The observation that expression of the Bub1 dimer interferes with chromosome 
bi-orientation is also worth following-up. Bub1 is important for phosphorylating histone 
2A, which allows the recruitment of Sgo1 to the centromere to establish chromosome bi-
orientation [7-9]. A high concentration of the Bub1 dimer may affect chromosome bi-
orientation by sequestering the Bub1 targets away from the kinetochore. Determining the 
localization of the Bub1 dimer as well as the known downstream effectors such as Sgo1 
will be an important step towards understanding the effect of the Bub1 dimer on 
chromosome bi-orientation. Furthermore, we can look at the dynamics of microtubule 
attachment in cells expressing Bub1-LacI to see whether the decrease in bi-oriented 
chromosomes is due to defect in fixing improper attachment or failure to stabilize correct 
microtubule binding.  
 
  
 ! 123 
Metaphase Arrest By the Mad2-Mad3 Fusion 
We do not yet have a complete picture of how the Mad2-Mad3 fusion arrests cells 
in metaphase. Our results suggest that the tight binding of the Mad2-Mad3 fusion to 
Cdc20 lead to inhibition of APCCdc20 and thus metaphase arrest. While the Mad2-Mad3 
fusion is indeed able to bind Cdc20 (described in Appendix Two), additional experiments 
are needed to determine the exact nature of this interaction. It will also be interesting to 
address the molecular details of the inhibition of APCCdc20 activity by the Mad2-Mad3 
fusion. One aspect we can look at is the stability of Cdc20 during metaphase arrest. 
Normally when the spindle checkpoint is activated, the half-life of Cdc20 is reduced and 
results in lower Cdc20 protein levels, which is important for preventing premature APC 
activation [10, 11]. In contrast, when cells are arrested in metaphase by Mad2-Mad3 
expression, the protein level of Cdc20 in the cells remains stable (described in Appendix 
Two). We speculate that the difference in Cdc20 stability is due to the distinct roles of 
Mad2 and Mad3 in inhibiting APCCdc20. Mad2 binds to the N-terminus of Cdc20 and 
interferes with the interaction between APC and the C-box of Cdc20, thereby inhibits 
activation of APC [12, 13]. On the other hand, Mad3 prevents Cdc20 from binding to its 
substrates, for example by occupying the KEN box-binding site of Cdc20 [13-16]. When 
the spindle checkpoint is activated, Cdc20 interacts with both Mad2 and Mad3, and the 
interactions are likely very dynamic. During instances when Cdc20 associates with Mad3 
but not Mad2, Cdc20 can still bind APC through its C box, even though Cdc20 cannot 
bind to APC substrates and target them for ubiquitination. In the absence of these 
substrates, the APC will ubiquitinate Cdc20 and target its destruction. This accounts for 
the increased degradation of Cdc20 during checkpoint activation. When the Mad2-Mad3 
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fusion binds Cdc20, both Mad2 and Mad3 will associate with Cdc20 at the same time. 
The binding of Mad2 prevents the interaction between Cdc20 and APC and therefore 
stabilizes Cdc20, thus explaining why the level of Cdc20 stays relatively constant in cells 
arrested by Mad2-Mad3 expression. One potential way to test this model is to carry out in 
vitro APC assays to carefully determine the effect of the Mad2-Mad3 fusion on the 
binding of Cdc20 to APC as well as APC activity. In addition, we can introduce Mad1 
and the Bub1 dimer to the system to further mimic checkpoint activation in vitro. This 
may ultimately allow us to biochemically determine how the reactions that start at the 
kinetochore lead to changes in the ability of Mad2 and Mad3 to bind to Cdc20 and inhibit 
the APC. 
We found that in addition to Mad2-Mad3, expression of two other protein fusions, 
Bub1-Mad2 and Bub1-Bub3, also activates the spindle checkpoint (discussed in 
Appendix One). Preliminary experiments showed that the metaphase arrest by these 
fusions require the presence of other checkpoint components, which suggest that the 
protein fusions are acting upstream in the checkpoint pathway similar to the Bub1 dimer. 
It will be interesting to further characterize their effects, and the findings from these 
experiments may provide additional insights into the interactions among checkpoint 
components that are important for checkpoint activation.  
 
Closing Remarks 
Overall our results demonstrate that manipulating the associations between 
checkpoint proteins can have a huge impact on spindle checkpoint activation. Cells thus 
have to carefully control the interactions among the spindle checkpoint components to 
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prevent undesired cell cycle arrest. How this is achieved is still poorly understood. Future 
work on this area may get us a little bit closer to the holy grail of the spindle checkpoint: 
understanding how events at a single kinetochore can generate a molecular signal that is 
potent enough to completely inhibit APC activity and arrest cells in mitosis.   
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Appendix One 
Spindle Checkpoint Activation by Checkpoint Protein Fusions 
 
 
Abstract 
We tested the effect of expressing different checkpoint protein fusions on cell 
cycle progression. In Chapter Four we discussed our finding that expression of a Mad2-
Mad3 fusion is sufficient to arrest cells in metaphase. Here we describe two other protein 
fusions, Bub1-Mad2 and Bub1-Bub3, which can also induce cell cycle arrest when 
overexpressed. Both of these fusions depend on other checkpoint components to activate 
the checkpoint, suggesting that they may mimic protein interactions that are important for 
upstream events in the spindle checkpoint pathway.  
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Introduction 
The ability of the Bub1 dimer to activate the spindle checkpoint (described in 
Chapter Three) motivated us to look at the effect of fusing different checkpoint proteins 
together. We found that expression of a Mad2-Mad3 protein fusion is sufficient to arrest 
cells in metaphase independently of other checkpoint components (discussed in Chapter 
Four), which is likely caused by the tight binding of the fusion to Cdc20.  
In this section we summarize our observations that expression of two other 
protein fusions, Bub1-Mad2 and Bub1-Bub3, can also induce metaphase arrest in cells. 
Unlike Mad2-Mad3, these fusions require other checkpoint components in order to 
activate the checkpoint. The protein fusions may thus recapitulate interactions that are 
important for initiating the spindle checkpoint pathway.  
 
Results 
 To determine the effect of fusing different checkpoint proteins, we tested the 
consequences of expressing different protein fusions from the GAL1 promoter in wild-
type yeast cells going through a synchronous cell cycle. We arrested the cells in G1 with 
!-factor, then released them into media with either glucose or galactose, and looked at 
them three hours later. Expression of Bub1-Bub3 and Bub1-Mad2, with the C–terminus 
of Bub1 fused to the N-terminus of either Bub3 or Mad2, led to accumulation of large 
budded cells and metaphase arrest (Figure A1-1). We also looked at the phenotype of 
expressing fusions of the checkpoint proteins at the opposite orientation (i.e. the C-
terminus of Mad2 or Bub3 fused to the N-terminus of Bub1). Expressing a Mad2-Bub1 
fusion still arrested the majority of the cells in metaphase, whereas expression of Bub3- 
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Figure A1-1. Expressing Bub1-Bub3 or Bub1-Mad2 protein fusions arrests cells in metaphase. 
Cells with the indicated PGAL1-driven genes were grown to mid-log phase, arrested in G1 with !-
factor, and were released into media with either glucose or galactose. After 3 hours of growth, the 
percentage of large budded cells was determined by light microscopy as a measure of metaphase 
arrest. Error bars represent the standard deviation of three independent trials. Two hundred cells 
were counted for each trial.   
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Bub1 had minimal effect on cell cycle progression (Figure A1-1). The metaphase arrest 
induced by Bub1-Bub3 may thus depend on how the two checkpoint proteins are fused 
together. One possibility is that the specific orientations of Bub1 and Bub3 in Bub1-Bub3 
are absolutely required for the downstream effects of the protein fusion. Alternatively, 
Bub3-Bub1 may fail to arrest cells simply because the checkpoint function of Bub3 is 
compromised when its C-terminus is fused to another protein, a proposal that could be 
investigated by testing for the biological activity of a Bub3-GFP fusion.  
We then asked whether the two protein fusions depend on other checkpoint 
components to induce metaphase arrest. We introduced the PGAL1-BUB1-BUB3 or PGAL1-
BUB1-MAD2 construct into yeast strains with different spindle checkpoint genes deleted 
(mad1!, mad2!, mad3!, bub1!, and bub3!) and again tested the effect of expressing the 
protein fusions. For both Bub1-Bub3 and Bub1-Mad2, cells failed to activate the 
checkpoint if they had deletion in the checkpoint gene that was not present in the 
expressed protein fusion  (Figure A1-2A and B). The results show that both fusions 
require other spindle checkpoint protein to arrest cells in metaphase.  
 
Conclusions and Discussion 
 We showed that expressing two protein fusions, Bub1-Bub3 and Bub1-Mad2, is 
sufficient to induce metaphase arrest in cells. Both fusions are able to activate the 
checkpoint only in the presence of other checkpoint components, suggesting that they 
contribute to events upstream in the checkpoint pathway that ultimately lead to inhibition 
of APC activity.  
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Figure A1-2. Checkpoint activation by Bub1-Bub3 and Bub1-Mad2 require most checkpoint 
components. Cells with (A) PGAL1-BUB1-BUB3 or (B) PGAL1-BUB1-MAD2 and deletion of the 
indicated checkpoint genes were released from G1 arrest into glucose- or galactose-containing 
media. The percentage of large budded cells was determined by light microscopy after 3 hours of 
growth. Error bars represent the standard deviation of three independent trials. Two hundred cells 
were counted for each trial.  
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How do these fusion proteins induce metaphase arrest in cells? One explanation is 
that similar to the Mad2-Mad3 fusion, Bub1-Bub3 and Bub1-Mad2 are able to bind to 
certain downstream checkpoint targets tightly, and the binding is sufficient to lead to cell 
cycle arrest. Given the role of Bub1 in bi-orienting chromosomes [1-3], the fusions may 
also sequester Bub1 targets away from the kinetochore and therefore affect chromosome 
bi-orientation, leading to mis-aligned chromosomes that in turn activates the checkpoint. 
Alternatively, the binding of Bub1 to Bub3 or Mad2 may be important for initiating 
downstream events in the spindle checkpoint and is normally carefully controlled. 
Expression of Bub1-Bub3 and Bub1-Mad2 fusions force Bub1 to constitutively interact 
with Bub3 or Mad2 and may thus lead to ectopic checkpoint activation. Future 
experiments are needed to further characterize the behavior of these protein fusions as 
well as to test possible models that explain how they arrest cells in metaphase. The results 
can potentially improve our understanding of the protein interactions that are important 
for spindle checkpoint activation.  
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Materials and Methods 
Yeast Strains and Methods 
 All strains are derivatives of W303 (ade2-1  his3-11,15  leu2-3,112  trp1-1  ura3-
1  can1-100), and are listed in Table A1-1. Strains were constructed using standard 
genetic techniques. All media were prepared using established recipes [4], and contain 
2% wt/vol of the indicated sugar as the carbon source.  
 
Cell Cycle Analysis by Light Microscopy 
 To look at the effect of overexpressing different checkpoint constructs on cell 
cycle progression, cells were first grown to mid-log phase (107 cells/ml) in YEP with 2% 
raffinose (wt/vol). Cells were then arrested in G1 by adding 10µg/ml !-factor (Bio-
Synthesis, Lewisville, TX) and incubated for 2 hours at 30oC. Cells were washed four 
times to remove !-factor and resuspended in YEP with either 2% glucose (wt/vol) or 2% 
galactose (wt/vol). After growing for 3 hours at 30oC, the cultures were briefly sonicated 
to separate cells that fail to dissociate completely after division and the percentage of 
large-budded cells in each sample was determined by light microscopy.  
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Table A1-1. Strains used in this Chapter.  
Strain Name Genotype 
DLY559 MATa  PGAL1-BUB1-BUB3@URA3 
DLY596 MATa  PGAL1-BUB3-BUB1@URA3 
DLY599 MATa  PGAL1-MAD2-BUB1@URA3 
DLY600 MATa  PGAL1-BUB1-MAD2@URA3 
DLY621 MATa  PGAL1-BUB1-BUB3@URA3  mad2!::Kanr 
DLY677 MATa  PGAL1-BUB1-BUB3@URA3  bub1!::Kanr 
DLY693 MATa  PGAL1-BUB1-BUB3@URA3  mad1!::HIS3 
DLY694 MATa  PGAL1-BUB1-BUB3@URA3  mad3!::Kanr 
DLY709 MATa  PGAL1-BUB1-MAD2@URA3  mad1!::HIS3 
DLY710 MATa  PGAL1-BUB1-MAD2@URA3  mad2!::Kanr 
DLY711 MATa  PGAL1-BUB1-MAD2@URA3  mad3!::Kanr 
DLY712 MATa  PGAL1-BUB1-MAD2@URA3  bub1!::Kanr 
DLY713 MATa  PGAL1-BUB1-MAD2@URA3  bub3!::Kanr 
DLY1198 MATa  PGAL1-BUB1-BUB3@URA3  bub3!::Kanr 
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Appendix Two 
The Interaction Between the Mad2-Mad3 Fusion and Cdc20 
 
 
Abstract 
In Chapter Four we described the observation that a Mad2-Mad3 protein fusion 
induces cell cycle arrest in budding yeast cells when it is overexpressed. The arrest is 
likely due to the ability of the fusion to bind and inhibit Cdc20. Supporting this model, 
we found that the Mad2-Mad3 fusion can associate with Cdc20 in vivo. We also showed 
that while Cdc20 is rapidly degraded when the spindle checkpoint is activated by 
microtubule poisons, the protein level of Cdc20 is stabilized during metaphase arrest 
induced by Mad2-Mad3 expression. Our results may reflect the roles of Mad2 and Mad3 
in inhibiting the activity of APCCdc20.  
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Introduction 
 Expressing a Mad2-Mad3 protein fusion can arrest cells in metaphase 
independently of other checkpoint components (discussed in Chapter Four). We speculate 
that the Mad2-Mad3 fusion can bind tightly to Cdc20, the main target of the spindle 
checkpoint, and the binding is sufficient to lead to the inhibition of Cdc20 and APC.  
To test the model that Mad2-Mad3 inhibits APC activity by binding to Cdc20, we 
looked at the interaction between the Mad2-Mad3 fusion and Cdc20. We showed that 
Mad2-Mad3 can in fact associate with Cdc20 in cells. In addition, we found that the 
protein level of Cdc20 remains relatively stable in cells that are arrested in mitosis by 
Mad2-Mad3 expression, which can potentially be explained by the effects of Mad2 and 
Mad3 on Cdc20 function.     
 
Results 
The Mad2-Mad3 Fusion Associates with Cdc20  
Both Mad2 and Mad3 associate with Cdc20 in budding yeast throughout the cell 
cycle [1, 2]. We performed coimmunoprecipitation (co-IP) experiments to test whether 
the Mad2-Mad3 fusion can also bind Cdc20. We introduced PGAL1-MAD2-MAD3-
3!FLAG into a strain that expresses epitope-tagged Cdc20 (18!Myc-Cdc20). We 
released the cells from G1 arrest into medium with galactose (to express Mad2-Mad3-
3!FLAG) for three hours, and prepared lysates from the cultures for co-IP. An anti-
FLAG immunoprecipitate contained both 18!Myc-Cdc20 and Mad2-Mad3-3!FLAG, 
showing that the Mad2-Mad3 fusion can bind Cdc20 (Figure A2-1). Similarly, both  
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Figure A2-1. The Mad2-Mad3 fusion associates with Cdc20. Cells carrying PGAL1- MAD2-
MAD3-3!FLAG and PCDC20- 18!Myc-CDC20 were grown to mid-log phase and arrested in G1 
with !-factor, and were released into medium with galactose to express Mad2-Mad3-3"FLAG. 
Extracts were made from the cultures and either Mad2-Mad3-3"FLAG (IP: anti-FLAG) or 
18"Myc-Cdc20 (IP: anti-Myc) was immunoprecipitated. The immunoprecipitates (IP) and the 
total lysates (Total) were then used for Western blots (WB) with anti-FLAG (to visualize FLAG 
tagged Mad2-Mad3) and anti-Myc (to visualize Myc tagged Cdc20) antibodies (n =3). Both 
Cdc20 and Mad2-Mad3 were found in the immunoprecipitates, showing that Mad2-Mad3 can 
bind Cdc20.  
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epitope-tagged Cdc20 and Mad2-Mad3 can be found in an anti-Myc immunoprecipitate, 
confirming that the two proteins can interact (Figure A2-1).  
 
Cdc20 is Stabilized in Cells Arrested in Metaphase by Mad2-Mad3 Expression 
 The Mad2-Mad3 fusion can potentially inhibit the activity of APCCdc20 through 
multiple mechanisms. The protein fusion may prevent APCCdc20 from recognizing its 
substrates. Mad2-Mad3 may also stimulate the degradation of Cdc20 and thus interferes 
with the activation of APC activity. To look at how expression of Mad2-Mad3 affects 
Cdc20, we monitored the level of epitope tagged Cdc20 (18!Myc-Cdc20) during cell 
cycle arrest. Cells carrying PGAL1-MAD2-MAD3 were released from G1 arrest into either 
glucose-containing medium (to inhibit expression of Mad2-Mad3) with benomyl and 
nocodazole (to depolymerize microtubule) or galactose-containing medium (to express 
Mad2-Mad3). After all the cells were arrested in metaphase, cycloheximide was added to 
the media to inhibit protein synthesis, and the protein level of Cdc20 was determined by 
Western blots. When the cells were arrested in metaphase by microtubule poisons, the 
level of Cdc20 decreased rapidly over time (Figure A2-2). Most of the Cdc20 
disappeared by 30 minutes after the addition of cycloheximide. The result agrees with 
previous reports showing that Cdc20 is degraded during checkpoint activation [3, 4]. In 
contrast, Cdc20 was stabilized in cells arrested by expression of the Mad2-Mad3 fusion 
(Figure A2-2). In the presence of both the Mad2-Mad3 fusion and microtubule poisons, 
the protein level of Cdc20 also remained stable (data not shown). Mad2-Mad3 thus 
prevents the degradation of Cdc20 that is normally observed when the spindle checkpoint 
is activated.  
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Figure A2-2. Expression of the Mad2-Mad3 fusion stabilizes Cdc20. The protein level of Cdc20 
was monitored by Western blots (n=3). Cells with Mad2-Mad3 under the GAL1 promoter and 
18!Myc-Cdc20 were grown to mid-log phase and arrested in G1 with "-factor, and were released 
into media with either glucose plus benomyl and nocodazole (top) or galactose (bottom). After 
two hours, cycloheximide (CHX) was added to the cultures to inhibit protein synthesis. Western 
blots against Myc (to visualize Myc-tagged Cdc20) or actin (loading control) were then 
performed. Cdc20 was rapidly degraded when cells are arrested in metaphase by microtubule 
poisons. On the other hand, the protein level of Cdc20 stayed relatively constant when Mad2-
Mad3 was overexpressed, indicating that the Mad2-Mad3 fusion stabilizes Cdc20.  
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Conclusions and Discussion  
 It is not clear how expression of the Mad2-Mad3 fusion is sufficient to arrest cells 
in metaphase. One model is that the fusion can associate with Cdc20 tightly, and this 
binding ultimately leads to the inhibition of APC activity and cell cycle arrest. We 
showed that Mad2-Mad3 fusion is able to bind Cdc20. Moreover, the protein level of 
Cdc20 stays relatively constant when cells are arrested in mitosis by the Mad2-Mad3 
fusion, indicating that the binding of Mad2-Mad3 to Cdc20 has a strong effect on its 
stability. 
Both Mad2 and Mad3 can interact with Cdc20 [1, 2], therefore it is not surprising 
that the Mad2-Mad3 fusion can also bind Cdc20. While the co-IP results agree with the 
hypothesis that Mad2-Mad3 inhibits APC activity by binding to Cdc20 tightly, we have 
to characterize the nature of this interaction to further support the model. One future 
direction is to perform in vitro biochemical assays using purified Mad2-Mad3 fusion and 
Cdc20 to determine whether the properties of the binding between these proteins are 
significantly different from that of the association between Cdc20 and Mad2 or Mad3 
alone.  
We showed that when the spindle checkpoint is activated by microtubule poisons, 
Cdc20 is rapidly degraded, confirming previous reports that Cdc20 is unstable during 
checkpoint activation [3, 4]. On the other hand, when cells are arrested in mitosis by the 
expression of Mad2-Mad3, the protein level of Cdc20 is stabilized. One explanation for 
the difference in Cdc20 stability is that Mad2 and Mad3 inhibit APC activity through 
different mechanisms. Mad2 binds to the N-terminus of Cdc20 and affect the interaction 
between Cdc20 and APC, which is important for the activation of APC [5, 6]. Mad3 is 
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important for preventing Cdc20 from binding its substrates, mainly by occupying the 
KEN box-binding site of Cdc20 [6-9]. During spindle checkpoint activation, Cdc20 
interacts with both Mad2 and Mad3, and these interactions are very dynamic. In cases 
when Cdc20 is bound by Mad3 but not Mad2, Cdc20 can still interact with APC through 
the C box, and APC will subsequently target Cdc20 for degradation. Cdc20 is thus 
degraded during checkpoint activation. In contrast, in the presence of the Mad2-Mad3 
fusion, Cdc20 always associates with both Mad2 and Mad3 at the same time since Mad2 
and Mad3 are linked covalently. The binding of Mad2 prevents the interaction between 
Cdc20 and APC, and Cdc20 is therefore stabilized in cells arrested in metaphase by 
Mad2-Mad3. One possible experiment to test this idea is to determine the stability of 
Cdc20 when it is tethered to either Mad2 or Mad3 using engineered leucine zippers. The 
results may ultimately explain how the Mad2-Mad3 fusion is able to inhibit the activity 
of APCCdc20.   
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Materials and Methods 
Yeast Strains and Methods 
 All strains are derivatives of W303 (ade2-1  his3-11,15  leu2-3,112  trp1-1  ura3-
1  can1-100), and are listed in Table A2-1. Strains were constructed using standard 
genetic techniques. All media were prepared using established recipes [10], and contain 
2% wt/vol of the indicated sugar as the carbon source. To prepare media containing 
benomyl and nocodazole, DMSO stocks of methyl 1-(butylcarbamoyl)-2-
benzimidazolecarbamate (benomyl) (Sigma-Aldrich, St. Louis, MO) and nocodazole 
(Sigma-Aldrich, St. Louis MO) were added to yeast extract and peptone (YEP) with 2% 
wt/vol glucose to a final concentration of 30µg/ml of each drug.  
 
Co-Immunoprecipitation  
 For immunoprecipitation experiments, cells were grown to mid-log phase (107 
cells/ml) in 20 ml of YEP with 2% raffinose (wt/vol). Cells were then arrested in G1 by 
adding 2µg/ml !-factor (Bio-Synthesis, Lewisville, TX) and incubated for 2 hours at 
30oC. Cells were washed four times to remove !-factor and resuspended in YEP with 2% 
galactose (wt/vol).  After three hours of growth, cells were harvested by brief 
centrifugation and the pellets were immediately frozen with liquid nitrogen. Yeast 
extracts were made by vortexing frozen cell pellets in 200µl of lysis buffer (100mM 
NaCl, 50mL Tris-HCl pH7.5, 10% glycerol, 50mM NaF, 50mM Na-"-glycerolphosphate, 
2mM EDTA, 0.1% Triton X-100, 1mM Na3VO4, 1mM PMSF, protease inhibitor 
cocktail) and around 100µl of acid washed glass beads for three rounds of one minute, 
incubating on ice for one minute between each round. The resulting lysate was separated 
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from the glass beads and centrifuged at 14,000 rpm for five minutes at 4oC to remove 
insoluble material. A portion of the lysate was mixed with an equal volume of 2X SDS 
sample buffer (Total). 
Antibody was added to the remaining lysate at 1:50 dilution and incubated on ice 
for one hour. Samples were then transferred to 30µl of Protein A/G PLUS-agarose beads 
(Santa Cruz Biotechnology, Santa Cruz, CA) which had been equilibrated in lysis buffer. 
The beads were rotated at 4oC for one hour. The beads were then washed four times with 
lysis buffer and boiled in SDS sample buffer for ten minutes. The resulting samples (IP) 
were used for Western blotting.  
 
Cell Cycle Experiment to Look at the Stability of Cdc20  
 To look at the stability of Cdc20 during metaphase arrest, cells were first grown 
to mid-log phase (107 cells/ml) in YEP with 2% raffinose (wt/vol). Cells were then 
arrested in G1 by adding 2µg/ml !-factor (Bio-Synthesis, Lewisville, TX) and incubated 
for 2 hours at 30oC. Cells were washed four times to remove !-factor and resuspended in 
YEP with either 2% glucose (wt/vol) with benomyl and nocodazole or 2% galactose 
(wt/vol). After growing for 2 hours at 30oC, protein production was shut off by adding 1 
mg/mL cycloheximide (Sigma-Aldrich, St. Louis MO). At the indicated time points, 1ml 
samples of the culture were collected. Cells were pelleted by centrifugation for 1 min at 
room temperature. The supernatant was removed, and cell pellets were stored at -80oC. 
Cell pellets were lysed using a NaOH/"-mercaptoethanol-based protocol [11] and the 
resulting lysates were used for Western blots.  
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Western Blots 
Proteins samples were loaded onto and separated in 10% Criterion Tris-HCl 
polyacrylamide gel (Bio-Rad, Hercules, CA). Proteins were transferred overnight to 
nitrocellulose (Whatman, Picataway, NJ). Western blotting for Myc-tagged Cdc20 were 
performed using anti-Myc 9E10 antibodies (Roche Applied Science, Indianapolis, IN) at 
a 1:500 dilution, FLAG-tagged Mad2-Mad3 was detected with anti-FLAG antibodies 
(Sigma-Aldrich, St. Louis, MO) used at a 1:2000 dilution, and actin was detected with 
anti-actin antibodies (Abcam, Cambridge, MA) used at a 1:2000 dilution. Horseradish 
peroxidase-conjugated goat anti-mouse (Santa Cruz Biotechnology, Santa Cruz, CA) was 
used as the secondary antibody at a 1:2000 dilution. The secondary antibody was detected 
by SuperSignal West Dura Chemiluminescent Substrate (Thermo Fisher Scientific, 
Rockford, IL) and the blot was imaged with an AlphaImager (ProteinSimple, Santa Clara, 
CA).  
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Table A2-1. Strains used in this Chapter.  
Strain Name Genotype 
DLY1081 MATa  18!MYC-CDC20 @TRP1  PGAL1-MAD2-MAD3-3!FLAG@URA3  ssd1 
DLY1139 MATa  18!MYC-CDC20 @TRP1  PGAL1-MAD2-MAD3@URA3  ssd1 
 
  
 ! 148 
References 
1. Hwang, L. H., Lau, L. F., Smith, D. L., Mistrot, C. A., Hardwick, K. G., Hwang, 
E. S., Amon, A., and Murray, A. W. (1998). Budding yeast Cdc20: a target of the 
spindle checkpoint. Science 279, 1041–1044. 
2. Hardwick, K. G., Johnston, R. C., Smith, D. L., and Murray, A. W. (2000). MAD3 
encodes a novel component of the spindle checkpoint which interacts with Bub3p, 
Cdc20p, and Mad2p. The Journal of Cell Biology 148, 871–882. 
3. Pan, J., and Chen, R.-H. (2004). Spindle checkpoint regulates Cdc20p stability in 
Saccharomyces cerevisiae. Genes & Development 18, 1439–1451. 
4. Nilsson, J., Yekezare, M., Minshull, J., and Pines, J. (2008). The APC/C maintains 
the spindle assembly checkpoint by targeting Cdc20 for destruction. Nat. Cell Biol. 
10, 1411–1420. 
5. Kimata, Y., Baxter, J. E., Fry, A. M., and Yamano, H. (2008). A role for the 
Fizzy/Cdc20 family of proteins in activation of the APC/C distinct from substrate 
recruitment. Molecular Cell 32, 576–583. 
6. Chao, W. C. H., Kulkarni, K., Zhang, Z., Kong, E. H., and Barford, D. (2012). 
Structure of the mitotic checkpoint complex. Nature. 
7. Burton, J. L., and Solomon, M. J. (2007). Mad3p, a pseudosubstrate inhibitor of 
APCCdc20 in the spindle assembly checkpoint. Genes & Development 21, 655–
667. 
8. King, E. M. J., van der Sar, S. J. A., and Hardwick, K. G. (2007). Mad3 KEN 
boxes mediate both Cdc20 and Mad3 turnover, and are critical for the spindle 
checkpoint. PLoS ONE 2, e342. 
9. Sczaniecka, M., Feoktistova, A., May, K. M., Chen, J.-S., Blyth, J., Gould, K. L., 
and Hardwick, K. G. (2008). The spindle checkpoint functions of Mad3 and Mad2 
depend on a Mad3 KEN box-mediated interaction with Cdc20-anaphase-
promoting complex (APC/C). J. Biol. Chem. 283, 23039–23047. 
10.  Sherman, F., Fink, G., and Lawerence, C. (1974). Methods in Yeast Genetics, 
(New York: Cold Spring Harbor Laboratory Press). 
11. Kushnirov, V. V. (2000). Rapid and reliable protein extraction from yeast. Yeast 
16, 857–860. 
 
 
 
